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INTRODUCTION
The 31st Stoneburner Lecture Series was
planned to present an overview of some important
aspects of clinical nephrology that we hope are of
interest to a wide audience. The faculty for this symposium was drawn largely from the Medical College
of Virginia N ephrology Division, and we were fortunate to have Dr. George E. Schreiner, Professor of
Medicine at Georgetown University and a long-time
friend, as our Stoneburner Lecturer.
Nephrology has grown to a full-fledged specialty
in only 20 years; knowledge in the field has burgeoned, and our understanding of renal diseases has
changed dramatically in that time. Renal transplantation is now a routine procedure and chronic
dialysis programs abound. So routine have these
therapeutic modes become that we may lose sight of
their costly and awesome social implications.
The audience attending this lecture series came
from several states and represented various medical
disciplines. They entered freely into the discussion
and thus contributed greatly to the value of the presentations. We offer thanks to them, to the lecturers
whose presentations are summarized in this issue of
the MCV QUARTERLY, and to the Department of
Continuing Medical Education whose planning for
this symposium was both thorough and efficient.
DONALD E. OKEN, M.D.
Professor of Medicine, and Chairman,
Division of Nephro/ogy

Cancer and the Kidney
DONALD E. OKEN, M.D .
Professor of Medicine, and Chairman, Division of Nephrology, Medical College of Virginia, Health Sciences
Division of Virginia Commonwealth University, Richmond, Virginia

Cancer of the kidney is associated with a bewildering array of extrarenal symptoms, and conversely,
tumors far removed from the kidney produce intriguing renal functional abnormalities.
A variety of extrarenal complications are seen
with hypernephromas, most of which rarely accompany Wilms tumors which grow rapidly and generally
occur before the age of 7. Wilms tumors are quite
susceptible to radiation therapy and surgery, and are
to be strongly suspected when hypertension and an
abdominal mass are found in a small child. Unless
treated, they rapidly cause death and usually leave
little opportunity for the patient to develop the striking extrarenal manifestations seen with hypernephroma.
Among the fascinating complications of hypernephromas (Table I) is first, the extremely slow
growth rate of a sizable minority of them. I have seen
patients known to have hematuria for up to three
years prior to the time that the tumor was found and,
on reviewing the intravenous pyelogram done at the
onset of hematuria, seen evidence that a renal mass
had been present all along . Those tumors which do
grow slowly may result in generalized amyloidosis
both in the kidney and elsewhere. Another peculiarity
of the hypernephroma, which is almost unique to this
tumor, is the disappearance of metastases once the
primary tumor has been removed. In only a few
instances has there been histologic evidence that the
"metastatic" lesions were indeed derived from a renal
cell carcinoma. Nevertheless, the phenomenon of
spontaneous regression of metastases seems well esThis paper is supported by USPHS Grant #AM 20132.
Correspondence and reprint requests to Dr. Donald Oken,
Division of Nephrology, Box 197, Medical College of Virginia ,
Richmond , VA 23298.
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tablished and offers at least a gleam of hope for those
in whom pulmonary metastases are found .
Perhaps equally remarkable is the finding of distant metastases many years after a renal cell carcinoma is removed surgically . The longest recorded
survival between a diagnosis of renal carcinoma and
the eventual death of a patient whose neoplasm was
considered inoperable and left in place is 37 years. 1
Many patients have been reported to develop metastases 5, 10, and even 25 years after the resection of a
hypernephroma. I have seen a patient who developed
"solitary" metastases sequentially over a 19-year period before he succumbed. Unfortunately, while such
cases stand out, metastases appear earlier in most
patients and lead to death within two years in one
third of patients.
Renal cell carcinoma also tends to extend via the
renal vein lumen into the inferior vena cava. Such a
circumstance is reported to occur in almost 10% of
patients with hypernephromas, 2 and a substantial
proportion of these tumors extends all the way up the
vena cava into the right atrium. 3 The extending tumor usually is restricted to the venous lumen without
penetration of the vessel wall and, as a result, is
generally removable in its entirety. Surprisingly, such
vascular involvement a lone does not appear greatly
to alter the prognosis at 5 or I 0 years, 4 and extraction
of the tumor mass is often both possible and desirable.
Fever, unexplained by infection, is a common
concomitant of hypernephroma. Melicow and Uson&
have reported that 16% of 577 cases of renal carcinoma presented with fever, often with weakness, anorexia, and weight loss, without any urologic symptoms whatsoever. A much higher percentage
combined these systemic manifestations with hematuria, an abdominal mass, or pain . Thus, it is not
111
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TABLE I
Peculiarities of Hypernephromas
1.
2.
3.
4.
5.
6.
7.
8.
9.

Slow growth frequent
Disappearance of metastases (rare)
Cause of occult fever (FUO)
Renal vein/ vena cava spread
Nonmetastatic hepatic dysfunction
Benign nephrohepatomegaly
Polycythemia, leukemoid reaction , eosinophilia
Heart fai'lure
Spontaneous rupture of kidney

uncommon for patients with hypernephroma to present with "fever of unknown origin" and a baffling
clinical picture. The fever may be low-grade and constant or intermittent and hectic, temperatures reaching 39.5 C (103 F) and higher.
First described in 1961,6 a syndrome of nonmetastatic hepatic dysfunction (NHDS) accompanies
the systemic abnormalities mentioned above in some
10% of patients with hypernephromas, 7 and presents
with hepatomegaly which differs both functionally
and histologically from the benign hepatomegaly frequently encountered with such tumors.a Here, biochemical abnormalities include elevated serum alkaline phosphatase concentrations, hypoalbuminemia,
and hyperglobulinemia. Liver biopsy may reveal nonspecific inflammatory infiltrates, fatty deposition, degenerative and regenerative changes of liver cells, and
areas of focal necrosis.a The syndrome may mimic
metastatic disease of the liver from which it must be
distinguished in that it is potentially reversible after
nephrectomy is performed; recognition of NHDS
may suggest a diagnosis of previously unrecognized
hypernephroma.
Reviews of polycythemia generally include hypernephroma in the list of causes, but in fact, polycythemia has been associated with this tumor in only
1% to 4% of most reported series. 10 Actually, anemia
is more the rule than the exception whether or not the
patient has had significant hematuria. 11 Eosinophilia,
thrombocytosis, leukocytosis, and even leukomoid
reactions occur in significant association with hypernephromas.12 Coupled with fever of unknown origin,
or alone, such findings may present vexing diagnostic
problems.
As in many other types of malignancy, thrombophlebitis accompanies renal cell carcinoma with
some frequency. Varicocele, particularly when on the
right, may be the first clue to the existence of a renal
tumor.

Hypertension is recorded in more than 20% of
the patients with hypernephroma and in some cases,
at least, the hypertension has been cured by nephrectomy .5 In others, hypertension is not surgically correctable, and it is difficult to be sure that the tumor
was causally related. The renal tumor most clearly
associated with hypertension is the "juxtaglomerular
cell" tumor. Neoplastically benign, this growth, originating in macula densa tissue, produces huge
amounts of renin with resultant secondary hyperaldosteronism and the complications attendant upon
that condition. It is mentioned here as a rare but
fascinating renal tumor which produces signs and
symptoms which may erroneously suggest the existence of renal arterial stenosis or venous obstruction
secondary to the spread of renal adenocarcinoma or
the hyperreninism sometimes associated with Wilms
tumors.13
Uncommon but life-threatening vascular complications of hypernephromas include high-output
congestive heart failure and spontaneous rupture of
the kidney with hemorrhagic shock. Heart failure is
attributable to highly vascular metastases with arteriovenous communications analogous to those observed in Paget disease. 14 Spontaneous rupture produces massive retroperitoneal hemorrhage closely
resembling a ruptured aortic aneurysm and is equally
lethal. 15
Renal Complications of Extrarenal Malignancies
Space does not permit a detailed discussion of
the many abnormalities of renal function found in
subjects with malignant diseases; however, I shall
comment upon the fluid and electrolyte disorders
which frequently occur (Table 2), and discuss the
nephrotic syndrome associated with malignancy.
Hypercalcemia may result from bony metastases
or the forced immobilization of acutely ill patients.
Certain cases are the result of parathormone secreting
tumors which function autonomously, 16 and a growing number of reports have called attention to the
existence of prostaglandin-secreting tumors producing hypercalcemia which may be reversed with indomethacin.17 The hypercalcemia caused by both hormone-secreting tumors is reversible with complete
removal of the tumor. Persistence of hypercalcemia
after the primary tumor is excised may reflect the
other causes of hypercalcemia (see Table 2), or be the
result of metastases which, like the parent tumor, also
synthesize prostaglandins or parathormone.
Hypercalcemia, if severe, may have devastating
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TABLE 2
Electrolyte Abnormalities with Nonrenal Malignancies
I. HYPERCALCEMIA-producing severe volume depletion and functional renal failure , nephrolithiasis or nephrocalcinosis:
a. Metastases
b. Corticosteroid withdrawal/adrenal insufficiency
c. Prostaglandin-secreting tumors
d. Forced immobilization
e. Parathormone-secreting tumors

2. VOLUME DEPLETION AND HYPONATREMIA •-producing functional renal failure:
a. Hypoadrenalcorticism of tumor replacement, amyloidosis, surgical ablation of the adrenals, disseminated intra vascular coagulation
(DIC).
b. Excessive diuretic therapy for peritoneal metastases or mechanical edema.
c. Rapidly developing ascites and edema
d. Extrarehal electrolyte losses:secretory diarrheas, villous adenomas , drug Rx hyperemesis, intestin al obstruction, malabsorption and
carcinoid.
•To be distinguished from the syndrome of inappropriate ADH secretion (CNS tumor/ metastases, vasopressin-secreting tumors,
vincristine/ cyclophosphamide therapy, and tricyclic anticonvulsants) where renal function does not specifically become impaired.
3. VOLUME DEPLETION AND HYPERNATREMIA-with functional renal failure:
a. Diabetes insipidus of pituitary replacement, brain metastases, urinary outflow obstruction.
b. Impaired thirst mechanism-organic or functional results of cachectic illness.
c. Kaliopenic and hypercalcemic nephropathy
d . Nasogastric feeding-osmotic diuresis
4. KALIOPENIC NEPHROPATHY-with impaired concentrating capacity and susceptibility to pyelonephritis:
a. Pernicious gastrointestinal electrolyte loss (see section 2)
b. " ACTH"-producing tumors
c. Juxtaglomerular cell tumors
d. Improper diuretic therapy
e. Lysozymuric and nonlysozymuric leukemias

effects upon the kidney, producing severe volume
depletion and functional renal failure, nephrolithiasis
with infection and urinary outflow obstruction, or
severe tubulointerstitial disease due to nephrocalcinos1s.
Volume depletion and hyponatremia are frequent complications which plague the patient with
malignant disease. Generically, the concurrence of
volume depletion and hyponatremia reflects a state in
which both sodium and water are lost from the body
in large amounts but the net sodium loss exceeds the
water deficit. Causes include adrenal insufficiency
owing to tumor replacement, adrenal amyloidosis,
surgical ablation of the adrenals as a therapeutic
adjuvant, and disseminated intravascular coagulation. Ill-advised sodium restriction with vigorous
diuretic therapy in an attempt to minimize mechanical edema or ascites due to peritoneal metastases is a
reasonably common cause of hyponatremic volume
depletion. The rapid development of ascites and
edema in sodium-restricted patients is another cause.
Massive electrolyte losses may occur through the in-

testinal tract as a result of the hyperemesis associated
with cancer chemotherapy, the secretory diarrheas
[amine precursor uptake and decarboxylation
(APUD) syndromes], mucus-secreting intestinal
tumors, intestinal obstruction, or malabsorption.
Massive fluid losses may be seen in the carcinoid
syndrome. The severe volume depletion .attendant
upon these complications may produce major abnormalities in renal function unless corrected.
Hyponatremia may also be seen in the presence
of extracellular fluid volume expansion-the socalled syndrome of inappropriate antidiuretic hormone (ADH) secretion. Causes include vasopressinsecreting tumors (especially of lung), primary or
metastatic intracranial malignancies, vincristine or
cyclophosphamide therapy to retard tumor growth,
and ~he tricyclic anticonvulsants .18
Volume depletion may coexist with hypernatremia for a variety of reasons. Diabetes insipidus
may result from tumor invasion of the pituitary
gland, intracranial metastases, or urinary outflow obstruction. Nasogastric feeding of concentrated solu-
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tions lacking in free water is a common cause of an
obligatory solute diuresis. Impaired thirst due to either organic brain disease or as a functional result of
a cachectic illness may contribute greatly to the development of hypernatremic volume depletion, a situation which is further aggravated if kaliopenic or hypercalcemic nephropathy is present.
Kaliopenic (hypokalemic) nephropathy is manifested by impaired concentrating capacity and an
increased susceptibility to pyelonephritis. It may result from pernicious gastrointestinal electrolyte
losses, hyperadrenal corticism secondary to an adrenocorticotropic hormone (ACTH)-producing tumor, juxtaglomerular cell tumors, or improper diuretic management. Major degrees of hypokalemia
may be seen in patients with leukemia, especially
those leukemias associated with lysozymuria. 19 Impaired concentrating capacity may well lead to serious volume depletion and secondary renal dysfunction.
Nonelectrolyte-related abnormalities of the urinary tract are listed in Table 3, but cannot be covered
in detail in this brief review.
Nephrotic Syndrome Associated with Malignancy
An increasing number of reports amply document the association of the nephrotic syndrome with
TABLE 3
Nonelectrolyte Renal Complications of Malignancies
I.
2.
3.
4.
5.
6.
7.
8.
9.

JO.
11 .
12.
13.
14.
15.
16.
17.
18.
19.
20.

Fanconi syndrome
Renal tubular acidosis
Hydronephrosis-obstructive renal failure
Renal amyloidosis
Urate nephropathy
Radiation nephritis
"Citrovorum rescue," antimetabolite nephropathy
Myeloma kidney
Renal hemorrhage, outflow obstruction
Cortical necrosis post-disseminated intravascular coagulation (DIC)
Tumor-related lupus erythematosus (especially with
lymphoma )
Renal vein/ arterial or vena caval occlusion
Vasomotor nephropathy-hemorrhage, sepsis, shock,
and so forth
Nephrolithiasis/ nephrocalcinosis
Obstruction of bladder outflow, ureters, or urethra by
tumor invasion
Renal invasion by metastases
Benign nephromegaly, etiology unknown
Retroperitoneal fibrosis/ tumor invasion, producing
ureteral obstruction
Nephrotic syndrome
Acute papillary necrosis, pyelonephritis

malignant tumors.20 Some cases are the result of
amyloidosis, others to renal venous outflow obstruction, and still others to probable immune mechanisms. Myeloma and lymphoproliferative disorders are
among the most common tumor-related causes of
amyloidosis, yet solid tumors also may cause amyloid
deposition if their course is not an accelerated one. 22
Invasion of the renal veins and vena cava by hypernephromas or other tumors, and compression of
venous structures by retroperitoneal nodes, tumor
mass, or retroperitoneal fibrosis may produce mechanical edema and marked proteinuria but are uncommon causes of the nephrotic syndrome.
Tumor-related nephrotic syndrome occurs with
some frequency in the absence of either amyloidosis
or venous obstruction, Hodgkin disease leading the
list of causes.21 Lymphosarcoma, chronic lymphocytic leukemia, and Burkitt lymphoma also have been
associated with frank nephrosis. 21 Of the solid tumors, bronchogenic carcinoma has been the most
often found. Malignancies of the stomach, colon,
breast, skin, ovary, oropharynx, and kidneys have
all been incriminated.
The majority of lymphoma-related cases have
shown minimal glomerular changes on biopsy or
postmortem study. Most other types of tumors have
produced membranous, proliferative or mixed membranous and proliferative lesions. Reversal of the
nephrotic syndrome after excision or chemotherapy
of the primary tumor has been observed by many
authors, the return of proteinuria signaling regrowth
of the malignancy 21
In this overview, I have tried to touch on the
highly complex interaction between carcinomatosis
and the kidney. The manifestations of this relationship are so diverse and numerous that it is well to
remember the adage, "Many a medical reputation
has been lost in the retroperitoneum." It is hoped
that continued awareness of the protean manifestations of tumors relating to the kidney will help to
preserve the reputations of all clinicians.
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Glomerulonephritis
WILLIAM F . FALLS, JR ., M .D.

Medical Service, Veterans Administration Hospital, and Department of Medicine, Medical College of Virginia,
Health Sciences Division of Virginia Commonwealth University, Richmond, Virginia

In this paper the histologic picture of the most
common disorders usually classified under the heading of glomerulonephritis will be reviewed, and the
subject of angiitis will be briefly addressed. A special
effort will be made to relate renal biopsy findings to
the immunologically mediated pathogenetic process
which is thought to be operative in each case. Where
it seems appropriate, a few comments will also be
made on clinical and pathological correlations. The
specific entities to be covered include: diffuse proliferative glomerulonephritis; focal proliferative glomerulonephritis; membranous glomerulonephritis; a ntibasement membrane antibody disease; rapidly
progressive glomerulonephritis (crescentic disease);
membranoproliferative glomerulonephritis; lipoid
nephrosis (nil disease); focal, segmental, and global
sclerosis; polyarteritis nodosa; hypersensitivity angiitis; and Wegener granulomatosis. Few comments
will be made about therapy because that subject is
covered elsewhere in this issue. The review will be
concluded by a discussion of the prognostic value of
information gleaned from careful biopsy evaluation.
Two types of immunologic injury to the kidney
have been clearly defined in experimental models and
are thought to have distinct clinical counterparts. 1
These are immune-complex mediated disease and
antibasement membrane antibody disease. The
former is the most common and will be considered
first.

Immune-Complex Glomerulonephritis
The pathogenesis of several glomerulonephritic
patterns to be discussed subsequently seems to be of
Correspondence and reprint requests to Dr. William F. Falls,
Jr., Renal Section, VA Hospital, Richmond, VA 23249.
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this type. In the classic immune-complex model, the
following sequence of events is thought to occur: an
antigenic substance gains access to the bloodstream
and is delivered to immunologically competent cells
which begin making antibody in response to the challenge; as antibody is released into the circulation, it
combines with antigen to form complexes. Under
certain circumstances of antigen excess, the complexes which are formed are small and soluble and
are not phagocytized in the reticuloendothelial system; these activate the complement cascade via the
classic pathway (C 1 ___, C 4 ___, C2 ___, C 3 ), and the entire
aggregate of antigen, antibody, and complement
components precipitates in the region of the glomerular basement membrane. The terminal components of
the complement system include substances which increase vascula r permeability and are leukotactic. An
increase in the permeability of the capillary wall leads
to leakage of protein into Bowman space a nd the
influx of leukocytes may cause proteolytic destruction of portions of the glomerular capillary wall; in
response to this assault, endothelial and mesangial
cell proliferation occur. Thus, any antigen capable of
stimulating an antibody response is a potential cause
of immune-complex mediated injury. As we shall see,
numerous inciting antigens have been identified, but
the pattern of injury may vary considerably, probably
depending on the nature of the antigen and the responsiveness of the host.2
Our understanding of the nature of immunologic
injury to the glomerular capillary has been enhanced
greatly by the development of immunofluorescent
staining techniques. In this process a quick-frozen
renal biopsy section is treated with a fluorescenttagged antibody against a specific class of human
globulin, complement component, or fibrinogen.
MCV QUARTERLY 14(3):116-123, 1978
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Fig 1-Immunofluorescent microscopic preparation (anti-IgG) of
a portion of a glomerulus from a patient with poststreptococcal
glomerulonephritis. Note "lumpy-bumpy" pattern. (X 1500).

Fig 2-Light microscopic preparation (H & E) of a portion of
renal biopsy from a patient with diffuse proliferative glomerulonephritis following streptococcal infection (X200).

When this preparation is viewed with fluorescent microscopy, a clear picture of the area of protein deposition is obtained. In the case of immune-complex
mediated disease, a "lumpy-bumpy" pattern will be
observed and is the hallmark of this type of injury.

ized by poststreptococcal glomerulonephritis but is
by no means specific to it. A similar light microscopic appearance may be seen in some patients with
lupus erythematosus, bacterial endocarditis, nephritis
associated with infected ventriculojugular shunts,
cryoglobulinemic nephropathy, and other antigenic
insults. 2 Diffuse proliferative glomerulonephritis secondary to lupus erythematosus can usually be distinguished from poststreptococcal disease because the
electron-dense deposits in lupus are usually located
on the subendothelial surface of the basement membrane (Fig 4) and discrete viruslike particles may also
be evident. 2 The site of deposition in other diseases is

Diffuse Proliferative Glomerulonephritis
Figure 1 is a photomicrograph of the imm unofluorescent staining for lgG in a patient with
acute poststreptococcal glomerulonephritis. Note the
coarse, granular deposition of the immunofluorescent material in the area of the capillary basement membrane and the mesangium. Figure 2 is the
light microscopic correlate of this lesion and shows
the characteristic picture of diffuse, proliferative glomerulonephritis. The glomerulus is swollen and the
capillary loops are occluded by proliferating mesangial and endothelial cells; there is marked hypercellularity and an influx of foreign inflammatory cells
is noted . Figure 3 is a high-power view of an electron
micrograph which demonstrates the classjc appearance and location of the electron-dense deposits
which are thought to represent the deposited complexes. Note that the deposits are quite large, "humplike," and located in a subepithelial position; the foot
processes in the area of the deposit have become
fused. This phenomenon of foot process fusion has
been found to correlate closely with the presence of
proteinuria.
The immunofluorescent and light microscopic
picture described above is typical of the aggressive
type of immune-complex mediated disease character-

Fig 3-Electron microscopic preparation of a portion of a glomerulus from a patient with acute poststreptococcal glomerulonephritis . Note large subepithelial electron-dense deposit, "hump" (X
32,000).
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Fig 4-Electron microscopic preparation of a portion of a glomerulus from a patient with systemic Iup us erythematosus and a
diffuse proliferative lesion by light microscopy. Note large subendothelial deposits (X 10,000).

variable, but in many cases with proliferative lesions
they are subendothelial.
In most cases of diffuse proliferative glomerulonephritis associated with lupus, one can find serologic
evidence of activation of the classic complement
pathway (low serum C 1q _, C 2 _, C 4 _, Cs). 2 Such
changes are variable in other diseases with proliferative lesions and in some cases of poststreptococcal
disease there may also be evidence of activation of the
alternate complement pathway. In this circumstance
Cs is activated directly, bypassing the earlier components. A number of substances are known to acti-

Fig 5-Light microscopic preparation (H & E) of a portion of a
renal biopsy from a patient with systemic lupus erythematosus,
showing a focal proliferative lesion (X 400).
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Fig 6-Red blood cell cast in urine sediment from a patient with
poststreptococcal glomerulonephritis (X 1,000).

vate Cs directly. These include endotoxin, properdin,
and IgA-containing complexes.
The course of immune-complex mediated proliferative glomerulonephritis is highly variable, depending on the disease process, and may well be related to
the supply of antigen. In lupus erythematosus there is
an inexhaustible supply of antigen in the form of
various nucleoprotein derivatives including doublestranded DNA.s As a consequence, lupus glomerulonephritis tends to be an ongoing, progressive disease.
On the other hand, poststreptococcal disease tends to
be self-limited, particularly in children,4 perhaps because of the rapid eradication of antigen from the
body.
Focal Proliferative Glomerulonephritis
Another histologic pattern of immune-complex
mediated glomerular injury is demonstrated in Figure
5. This is the pattern of focal (among glomeruli) and
segmental (within a glomerulus) glomerulonephritis.
By immunofiuorescence the deposited globulins tend
to be localized more within the mesangial region than
along the capillary walls, and IgA may frequently be
found along with other immune globulins and complement components. Evidence of alternate complement pathway activity may also be seen and it has
been suggested that IgA-containing complexes may
set this pathway in motion. 5
Focal proliferative lesions may be seen in a wide
variety of disorders including some patients with
lupus erythematosus, Schonlein-Henoch purpura,
and Berger disease (IgA nephropathy). 2
Figure 6 is the photomicrograph of a red cell
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Fig 7-Light microscopic preparation (PAS) of a portion of a
glomerulus from a patient with membranous glomerulonephritis
( X 200).

cast. This structure is considered to be characteristic
of inflammatory or necrotizing disease of the glomerulus. It is introduced at this time because, being the
most characteristic feature of the urine sediment in
patients with glomerulonephritis, it tends to correlate
with the type of proliferative lesions which have just
been described.
Membranous Glomerulonephritis
In each of the immune-complex mediated disorders mentioned above, the light microscopic picture demonstrated evidence of cellular proliferation

Fig 8- Light microscopic preparation (H & E) from renal biopsy
of a patient with rapidly progressive glomerulonephritis. Note
marked crescent formation by proliferating glomerular epithelial
cells (X 80).
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Fig 9-Immunoftuorescent preparation (IgG) from a portion of
biopsy of a patient with anti basement membrane antibody disease.
Note linear pattern of fluorescence. (X 1500).

and inflammation . Such is ordinarily not the case in
membranous glomerulonephritis. Figure 7 demonstrates the typical light microscopic picture of this
lesion. The only recognizable abnormality is thickening of the basement membrane. On immunofluorescent and electron microscopic study this membrane alteration is found to be secondary to finely
granular deposition of immunoprotein along the subepithelial border of the basement membrane. In addition to IgG and IgM, complement components may
be deposited. Why this deposition is not associated
with the induction of an inflammatory reaction like
that described above is unclear. In animal models
similar lesions are associated with small, weak-affinity antibodies6 and it is possible that this is also true
in human disease.
A membranous pattern may be seen in a number
of clinical states including: lupus erythematosus, drug
intoxication (heavy metals, tridione, penicillamine ),
solid tumors (carcinoma of the lung and colon),
sickle cell disease, hepatitis B infection, and as an
idiopathic occurrence. 2 Patients with membranous
nephropathy usually present with a nephrotic state
characterized by edema, hypoalbuminemia, hypercholesterolemia, heavy proteinuria, and fat-filled
macrophages in the urine sediment.
Antibasement Membrane Antibody Disease
The second, well-established type of injury to the
glomerular capillary is that caused by circulating
antibasement membrane antibody. 1 In this disorder
antibodies, usually of the IgG class, develop against
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Fig IO-Electron microscopic representation of basem ent membrane reduplication in a patient with type I membran oproliferative
glomerulonephritis. (X 14,000).

Fig I I-Electron micrograph from a patient with membranoproliferative gl omerulonephritis type II . Note the homogeneous electron-dense deposit through out the basement membrane. (X
15,000).

some antigenic component of the basement membrane. These abnormal antibodies enter the circulation and are carried to the kidney where they attach
to antigens on the basement membrane. This reaction
of antigen and antibody activates the complement
cascade, probably via the classic pathway, and induces an inflammatory reaction in a manner analogous to that described earlier. Under certain circumstances there may be cross-reactivity of the
glomerular antibasement membrane a ntibody with
other basement membranes in the body, pa rticularly
the lung. It is this sharing of antigenic determinants
that is thought to lead to lung hemorrhage and glomerulonephritis in Goodpasture syndrome.7

is confirmed by electron microscopy which demonstrates electron-dense deposits. The common denominator of the crescentic pattern seems to be damage to the glomerular basement membrane of such a
magnitude that fibrinogen and other components
leak into Bowman space where the coagulation process is activated. This , in turn, stimulates proliferation
of epithelial cells and attracts an influx of macrophages.9 The picture of crescent formation and immun e-complex deposition may also be seen in diffuse
proliferative lupus and certain of the angiitic processes to be discussed later.

Rapidly Progressive Glomerulonephritis ( Crescentic
Disease)
A histologic picture of marked proliferation of
both visceral and parietal epithelial cells, leading to
extensive crescent formation (Fig 8) associated with a
rapidly progressive, downhill clinical course may be
seen under a number of different clinical circumstances.8 It is classically seen in the kidneys of patients with Goodpasture syndrome and in this setting
immunofluorescent staining invariably shows a linear
deposition of antibody (Fig 9). A crescentic pattern
may also be seen in patients with rapidly progressive
glomerulonephritis without lung hemorrhage. In this
circumstance only about 40% of the patients show an
immunofluorescent pattern which is indicative of
antibasement membrane antibody disease.2 The remainder show a "lumpy-bumpy" fluorescent pattern
indicative of an immune-complex pathogenesis. This

Glomerulonephritis in Which the Pathogenesis is Not
Clearly Defined: Membranoproliferative (Mesangiosclerotic Glomerulonephritis)
Great interest is currently being focused on lesions included under this heading10 ; its classification
is in a state of almost daily flux. On light microscopy
the glomeruli from patients with this type of lesion
show a lobular pattern which is associated with an
increase in both the cellular and acellular components of the mesangium. This type of lesion may be
seen in a variety of disease states including lupus
erythematosus and non-resolving poststreptococcal
glomerulonephritis. It is nonspecific in and of itself.
Typical membranoproliferative lesions have also
been described in children and adolescents who usually present with a nephrotic syndrome accompanied
by varying numbers of red blood cells and red blood
cell casts in the urine sediment. Early on, attention
was drawn to the fact that many of these children had
low levels of circulating C 3 and some had evidence of
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Fig 14-Light microscopic view of necrotic glomerulus (H & E)
from a patient with Wegener granulomatosus. ( X 500).
Fig 12-Electron microscopic preparation of a portion of a renal
biopsy from a patient with "nil disease." Note normal-appearing
basement membrane, the absence of deposits, and the presence of
fused foot processes ( X 14,000).

activation of the alternate complement pathway as
manifested by the presence of properdin in the glomerular mesangium .2 Careful evaluation of biopsies
with silver staining techniques revealed extensive
reduplication of the basement membrane. Electron
microscopic study confirmed this finding and suggested that the new basement membrane was laid
down by proliferating mesangial cells burrowing beneath the cytoplasm of the endothelial cells (Fig IO).
Subsequent evaluation of a larger number of cases
has revealed the presence of some lgG deposits and
early-reactive complement components in the mesangium. These patients have been classified as having
membranoproliferative glomerulonephritis, type I

Fig 13-Light microscopic representation (PAS) of renal biopsy
section from a patient with focal , segmental sclerosis. Note the
peripheral hyaline lesions in lower glomerulus while upper glomerulus is relatively spared. ( X 200).

and are thought to have a variant of a classic immune-complex mediated disease. At present there is
no clue as to the nature of the inciting antigen or
antigens.
Membranoproliferative glomerulonephritis, type
II, on the other hand, seems to be a more specific,
homogeneous disease entity, albeit poorly understood. This disorder is also seen more frequently in
younger individuals who usually present with a nephrotic syndrome. The light-microscopic biopsy picture
is indistinguishable from the lobular pattern with
basement membrane reduplication seen in type I. A
distinctive dense deposition involving all of the basement membranes is seen with electron microscopy
(Fig 11 ), 10 however, and positive immunofluorescent
staining is seen only for complement. The staining is
intense and seems to involve the same areas as the
electron-dense deposits. These abnormal histologic
changes accompany a blood chemical picture which
is characterized by low Ca levels, normal early-reacting complement components, and the presence of an
abnormal circulating globulin component which is
capable of activating Ca directly (Ca nephritic factor).
Type II membranoproliferative glomerular
nephritis is felt to be mediated via alternate pathway
complement activation alone. For reasons that are
not clear, type II disease has been observed with some
frequency in patients with partial lipodystrophy and
glomerulonephritis. Both type I and type II may
show recurrence in the transplanted kidney.

Lipoid Nephrosis of Childhood (Nil Disease)
Most young children who have a nephrotic syndrome display no recognizable abnormality on light
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or immunofluorescent microscopy of their renal
biopsy. The only recognizable change is fusion of the
epithelial cell foot processes (Fig 12) which can be
observed on electron microscopic section. This histologic pattern correlates with an essentially normal
urine sediment. If cellular elements are present in
more than very scant numbers, some other process
must be considered. A similar lesion has been noted
to occur in some patients with active Hodgkin disease
and to disappear with successful treatment of the
underlying disorder. This observation, taken in conjunction with the recognition that Hodgkin disease is
a T-cell related malignancy, has invited speculation
that the idiopathic nephrotic syndrome of childhood
may also be a manifestation of abnormal T-cell function.11 Such conjecture is interesting but entirely unproven.

Focal, Segmental, Global Sclerosis
Those young children with a nephrotic syndrome who have neither a spontaneous remission nor
a favorable response to steroid therapy probably
have this disorder. In most cases the initial involvement is deep in the juxtamedullary glomeruli,
and centrifugal progression occurs throughout the
entire cortex . In the focal lesion, some glomeruli are
involved by segmental areas of mesangial sclerosis or
hyalinization which are easily noted on light microscopy (Fig 13). Immunofluorescent studies may show
spotty, nonspecific staining for IgG and complement,
and electronmicroscopy demonstrates an increase in
mesangial matrix material with an occasional mesangial deposit. In patients with global sclerosis the
changes are similar but involve the entire glomerulus.
The etiology of this disorder is uncertain, but an
immune-complex mechanism is suggested by the
finding of immunoglobulins in the sclerotic lesions
and its occurrence in association with hepatitis B
infection. 12
Angiitis
The angiitic processes are probably immunologically induced and for our purposes may be divided
into three groups, depending on the size of vessels
involved and the presence or absence of granulomatous change.
Polyarteritis nodosa: Histologically this disorder
is characterized by necrotizing, inflammatory lesions
of medium-sized and large arteries. The hallmark of
this process in the kidney is the presence of ischemic
necrosis and infarction. Deposits of immune globu-
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fin, complement, and fibrin may be seen with immunofluorescent stains of the vessel walls. Clinically,
patients with this disturbance present with a picture
of hypertension, mononeuritis multiplex, central nervous system disturbances, and progressive renal insufficiency with an active urinary sediment.
Hypersensitivity angiitis: This is an angiitic process which involves small vessels including arterioles,
venules, and the capillary loops of the glomerulus.
Segmental necrosis of glomerular tufts may be seen
on light microscopy and there may be nonspecific
deposition of immune globulin and complement
noted by immunofluorescence and light microscopic
studies. Vasculitis of the skin is a frequent accompaniment of the renal lesions. This type of angiitis has
been reported as a manifestation of hypersensitivity
to a number of drugs. Hepatitis B infection has also
been described in association with this disorder. 13
Granulomatus arteritis: Wegener granulomatosis, the prototype of this disturbance, is characterized by the presence of necrotizing granulomas in
the respiratory tract and a necrotizing, proliferative
lesion of the renal glomerulus (Fig 14). Immunoglobulins and fibrin are deposited in a nonspecific glomerular pattern and crescents may be seen with frequency. Although thought to be of immunologic
origin , the antigenic stimulus for this disease is unknown.14

Prognosis of Immunologically Mediated Renal Injury
The question, Why do a biopsy? frequently
arises. Information from tissue examination should
be of value in determining the proper diagnosis, prognosis, and treatment. We have pointed out the diagnostic value in the histologic review above. The prognostic information to be gained may be substantial
and is outlined below.
As noted earlier, the course of a patient with an
immune-complex mediated diffuse proliferative lesion is variable and relates to the underlying disease
process . In those patients with an idiopathic lesion or
in lupus the prognosis is usually poor. Patients with
membranous lesions secondary to a recognized antigen which can be withdrawn or eradicated frequently
show remission or improvement. Thirty percent of
patients with an idiopathic nephrotic syndrome secondary to membranous nephropathy may have a
spontaneous remission whereas the course of the remainder tends to be indolently downhill with a continued nephrotic syndrome. Patients with crescentic
disease either related to an antibasement membrane
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antibody or to circulating immune complexes do
poorly. The prognosis in both types of membranoproliferative lesions is one of slow progression to endstage disease in 10-12 years. The prognosis in nil
disease is excellent with a high incidence of spontaneous remissions. Focal and global sclerotic lesions are
associated with a slow but inexorable deterioration in
renal function. The prognosis for untreated polyarteritis nodosa and Wegener granulomatosis is very
poor. A similar prognosis is seen with small vessel
angiitis unless it is drug-related in which case withdrawal of the offending agent may be accompanied
by improvement.
In summary, the histopathology of the more
common glomerulonephritic and angiitic lesions
which may be seen on renal biopsy has been reviewed . Their diagnostic and prognostic implications
have been discussed. Undoubtedly, the future will
bring alterations in the presently outlined classifications as our understanding of the underlying imm unologic pathogenetic mechanisms expands.
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The nephrotic syndrome represents one of the
major clinical problems in nephrology. It is usually
defined as the constellation of clinical findings which
includes edema, massive proteinuria, low serum albumin, high serum cholesterol, and the presence of oval
fat bodies in the urine.1 However, if we focus on the
primary disturbance in the patient, that is, massive
proteinuria, the nephrotic syndrome may be defined
more simply as the clinical and metabolic consequences of persistent and massive proteinuria. The
other manifestations listed in the classic definition are
all inconstant and secondary to this loss of protein
and may be found in other clinical disorders. Proteinuria is considered massive when it is greater than 3 .5
mg/ kg body weight per day, and persistent when
present for many weeks or months. For diagnosis of
the nephrotic syndrome, 24-hour urine protein excretion must be measured; a spot measurement is inadequate because some patients with massive proteinuria produce occasional specimens with little or
no protein.
In understanding potential causes of the nephrotic syndrome, it is useful to recognize two general
categories of disease. 2 •3 One is the nephrotic syndrome associated with systemic illnesses. The other is
not associated with a recognizable systemic process,
and thus reflects only intrinsic renal disease. The
most common systemic diseases associated with the
nephrotic syndrome are diabetes mellitus, systemic
lupus erythematosus, malignancy and amyloidosis.
Additionally, there is a large variety of other diseases
less commonly associated with the nephrotic synCorrespondence and reprint requests to Dr. Douglas M.
Landwehr, Division of Nephrology, Box 197, Medical College of
Virginia, Richmond , VA 23298.
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drome. Many of these involve immune and toxic
reactions related to drugs, as well as infectious and
environmental agents. Although these entities are uncommon, it is important to recognize them, as removal of the dn1g or toxin, or definitive treatment of
the infection, is a fundamental part of the management of these patients. Drugs shown to be associated
with the nephrotic syndrome include the antiepileptic
drugs paradione and tridione, anticoagulant agents,
and penicillin. Forms of allergic reactions associated
with the nephrotic syndrome include those following
bee sting or exposure to poison oak or poison ivy.
Chronic infections which are known to be complicated by the nephrotic syndrome include syphilis,
malaria, hepatitis and toxoplasmosis.
There are several intrinsic renal diseases which
cause the nephrotic syndrome. Recognition of these
depends on characteristic morphologic findings in the
renal biopsy specimen. The first is the clinicopathologic entity referred to as nil disease or lipoid
nephrosis .2 As implied in the term nil disease, there is
little, if any, change in the normal architecture of the
kidney when examined by light microscopy; however,
electron microscopy does disclose changes of epithelial foot process fusion. Nil disease is the predominant cause of the nephrotic syndrome in children, particularly between ages 2 and 5 years; it is a
less common cause in adults, accounting for approximately 15% of adult cases of primary nephrotic syndrome.
The second intrinsic renal disease which causes
the nephrotic syndrome is a condition termed idiopathic membranous glomerulopathy2 and it is found
most frequently in adults . This term refers to the
morphological changes of diffuse thickening of the
basement membrane of all glomeruli. Within and to
MCV QUARTERLY 14(3):124-127, 1978
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the outside of the basement membrane are found
desposits which have been shown to contain immunoglobulins and serum complement components.
They are thought to result from the deposition of
circulating complexes of antigen and antibody, and
are responsible for injury to the glomerulus which
results in heavy proteinuria. Membranous glomerulopathy accounts for approximately 40% of the primary nephrotic syndrome in adults . It is relatively
uncommon in children in the United States.
A third intrinsic renal disease which causes
nephrotic syndrome is termed membranoproliferative glomerulonephritis. 3 In this disease the mesangial
or supporting cell of the glomerulus is affected. Although the cause of this disease is not understood,
immune deposits may be found in the mesangial area.
This is an uncommon cause ofnephrotic syndrome in
adults but is perhaps the most common cause in
patients aged I 0 to 20 years. Prognosis for this disease is not good as its course commonly leads to
renal failure .
The fourth intrinsic disease recognized as causing the nephrotic syndrome is termed focal sclerosing
glomerulonephritis. 2 •3 As this pathologic term indicates, the lesion involves a process which at first is
confined only to parts of individual glomeruli. Again,
the cause is unknown, although immune deposits are
found in the areas of scarring. Like membranoproliferative glomerulonephritis, this disease also frequently results in renal failure.
In managing patients with the nephrotic syndrome, it is useful to bear in mind the pathophysiology of the syndrome. Although the most frequent concern is with the development of massive
edema, it should be remembered that such edema is a
consequence of massive loss of protein into the urine.
This in turn leads to depletion of intra vascular albumin and reduction of plasma oncotic pressure. In
turn, fluid escapes from the vascular compartment
into the interstitial tissue. As a compensatory response to the fall in plasma volume, there is decreased salt and water excretion by the kidney which
may further increase the accumulation of edema. If
intravascular albumin depletion can be prevented or
reversed, significant problems with edema and fluid
retention will not develop. As albumin depletion is
caused primarily by loss through a leaky glomerulus,
the first approach, if possible, should be to reverse the
albumin leak . As we shall see later, this is regularly
accomplished only in nil disease in which the leak is
predictably corrected by steroids. In other conditions
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in which the albumin leak is not remedial, metabolic
considerations should be first and foremost in management. A high-protein and high-caloric diet can
result in significant repletion of intravascular albumin.5 To the extent that albumin loss can not be
matched by increased dietary protein, then salt restriction and diuretics may be necessary to prevent
undue accumulation of edema. From a practical
standpoint, the diet of the nonazotemic patient
should contain a minimum of 100 gm of high-quality
protein and approximately 3,500 calories for the average nephrotic adult. At times, protein intake of 2-3
gm / kg of body weight will be required. Since many of
these patients are anorectic and have been grossly
malnourished for some time, the diet may have to be
increased gradually until these goals are accomplished. This will require persistent and close cooperation between the patient, the physician, and the
dietitian .
If serum albumin remains severely depressed despite optimal intake of protein, it is probable that salt
and water restriction, as well as diuretics, may be
necessary for control of severe edema. One must remember that, although there may be massive accumulation of edema, there is at the same time potential
for significant intravascular volume depletion. Therapy designed to reduce edema accumulation may further reduce intravascular volume, and potentially result in shock. Judicious use of salt restriction and
diuretics is necessary in order to achieve the appropriate balance in which severe accumulation of
edema is prevented without unduly jeopardizing intravascular volume. In general, this involves sodium
restriction of approximately 40-60 mEq/p day. Diuretics should be adjusted so that edema is not reduced to the point where postural changes in blood
pressure and pulse occur. Although this may involve
some trial and error, one can usually arrive at a body
weight in which massive edema is prevented but not
at the expense of severe volume depletion.
The nephrotic syndrome may also be complicated by increased susceptibility to infection. Prior
to the introduction of steroid and antibiotic therapy,
pneumococcal pneumonia and/or peritonitis was a
major cause of death in nephrotic children. This is at
least in part because of loss of immunoglobulins in the
urine. In addition, protein malnutrition and edematous tissue may contribute to reduced host defenses.
It is not always possible to prevent the loss of immunoglobulins in the urine of patients with persistent,
heavy proteinuria, but massive edema and malnutri-
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tion are potentially correctable. It is most important
that the physician be alert to early signs of infection
in these patients so that they are treated definitively
and aggressively.
An increased thromboembolic tendency is an
additional potential complication of the nephrotic
syndrome. Although the mechanism is not clearly
understood, there are data to suggest that a hypercoagulable state may exist in association with the
nephrotic syndrome. Care should be taken that other
factors, such as venous stasis, which predispose to
thromboembolism, be avoided in order to minimize
this risk. It is also important that those providing
medical care for these patients be especially attuned
to this problem, so that definitive diagnosis and treatment may be accomplished at the earliest possible
time. There appears to be no basis for use of anticoagulant agents except in documented episodes of
pulmonary embolus. For unclear reasons, there
seems to be a predilection for the formation of clots
within the venous system of the nephrotic kidney.
Again, it appears that anticoagulants are not indicated except in the occurrence of a pulmonary embolus.
It has been conclusively demonstrated that patients with long-standing nephrotic syndrome may
develop accelerated atherosclerotic disease, leading
to an increased risk of coronary artery disease and
acute myocardial infarction; this appears to be related to prolonged hyperlipidemia. There is an inverse relationship between serum albumin and serum
lipid levels. Any maneuver which improves the serum
albumin level, such as correction of protein malnutrition, can be expected also to lower serum lipid levels.
Treatment with clofibrate does not appear to be
highly effective in treating hyperlipidemia associated
with the nephrotic syndrome and may be associated
with severe side effects if the dosage is not reduced to
correspond to the reduced serum albumin levels.
The most fundamental concern in management
of the nephrotic syndrome should be the correction
of increased glomerular protein leakage. If protein
loss can be reversed, all secondary problems will resolve. Two general considerations relate to abnormal
protein leakage. First, the physician should be aware
that the nephrotic syndrome could be a manifestation
of some reversible systemic process. Any drug, toxin,
or allergen which could potentially cause the nephrotic syndrome should be removed, if possible. Systemic diseases associated with the nephrotic syndrome, such as malignancy and chronic infections,

should be identified and treated definitively. Even
when malignancy is not curable, reduction in tumor
mass may lead to resolution of the nephrotic syndrome.
The second approach to treatment of glomerular
protein leakage involves the use of steroids and immunosuppressant agents. It has been shown conclusively in only one disease, nil disease, that these
agents can predictably reverse glomerular leakage of
protein; for the rest there is little evidence of efficacy
of such agents. In nil disease, treatment with prednisone, in doses of 40-60 mg/day/m 2 body surface area
in children and 1 mg/day/kg body weight in adults,
will result in a significant reduction in the level of
proteinuria within 7 to 28 days. In general, children
will respond quickly, and their proteinuria will fall
off rapidly to undetectable levels. Adults tend to respond more slowly and less completely but will usually have less than 1 gm of protein excretion per day
within the first 28 days of treatment. After clearing or
significant reduction in the level of proteinuria, treatment is usually switched to an alternate-day regimen
and the steroids reduced and subsequently discontinued over the next two to three months. Immunosuppressant agents, such as cyclophosphamide, may
be useful in some patients with nil disease who have
frequent relapses upon cessation of steroid therapy.
Recent evidence suggests that these agents may prevent or reduce the frequency of such relapses.
In addition to the beneficial effect of steroids and
immunosuppressant agents on the proteinuria of nil
disease, there is also a recent and ongoing interest as
to whether these agents may prevent or slow the rate
of progression of renal failure in glomerulonephritis
associated with the nephrotic syndrome. The severe
glomerulonephritis of systemic lupus erythematosus,
as well as idiopathic membranous and membranoproliferative glomerulonephritis, are diseases whose
prognosis may be improved by these agents; however,
studies supporting such conclusions have not been
adequately controlled and remain controversial.
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Acute renal failure following severe trauma,
shock, transfusion reactions, poisoning, and sepsis is
characterized by prolonged oliguria, increasing azotemia, isosthenuria, and a sodium concentration of
40-90 mEq/L. Despite the availability of intensive
medical and surgical care, potent antibiotics, and
dialysis, this syndrome still carries a mortality rate of
approximately 50% and once established cannot be
reversed by any known medical regimen. It is, however, often preventable, and the purpose of this paper
is to evaluate the efficacy of the various prophylactic
measures currently in vogue.
In searching for means of preventing acute renal
failure, we should consider three pathophysiologic
mechanisms involved that, historically, have received
the greatest attention:
I. The passive backflow theory,
2. Tubular obstruction, and
3. Vasomotor factors.
According to the passive backflow theory, glomerular filtrate is formed at a normal or close to
normal rate but is absorbed quantitatively and nonselectively across injured tubular epithelium. The
tubular obstruction theory presupposes that cell swelling and tubular debris occlude the tubule lumen,
raise intratubular pressure to the point that filtration
is seriously reduced, and/or augment the driving
force for passive backflow of the filtrate formed. The
vasomotor theory suggests that acute renal failure is
This paper is supported by USPHS Grant #Hl 19463.
Correspondence and reprint requests to Dr. Donald Oken,
Division of Nephrology, Box 197, Medical College of Virginia,
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the result of a primary failure of glomerular filtration
because of decreased glomerular capillary filtration
pressure with or without reduced permeability of the
filtration surface.
The renal cortical blood flow of human subjects
with acute renal failure has been found almost invariably to be greatly decreased. 1 -• Ifthis decrease in
blood flow relates only in part to an increased preglomerular vascular resistance as seems evident from
angiography, 5 glomerular filtration must be maximally suppressed. Although the possibility of inulin
leakage casts some doubt on the validity of inulin
clearance measurements which would confirm such a
near cessation of filtration, micropuncture studies of
experimental animals with acute renal failure have
provided unequivocal proof that glomerular filtration does, indeed, fail. 6 By and large, experimental
models reveal proximal tubular pressure to be distinctly low, not elevated as might be suggested by the
tubular obstruction theory. Although tubular leakage
of glomerular filtrate has been described by some
authors, tubular absorption has, for the most part,
been shown to be markedly decreased, rather than
increased as suggested by the passive backflow theory.7 Perhaps the most telling argument against this
theory can be derived from studies of chronically saltloaded rats poisoned with mercuric chloride. Such
animals, allowed l % saline solution in place of tap
water for a month prior to mercury injection, are
almost perfectly protected from renal failure. Their
blood urea nitrogen concentrations and whole kidney
inulin clearance values are close to normal 24 hours
after the injection of mercury. Nevertheless, their
kidneys show tubular necrosis which is just as severe
MCV QUARTERLY 14(3):128-131, 1978
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as that displayed by their water drinking counterparts
with virtually no renal function. 8 If the passive backflow theory is not applicable to kidneys with evident
necrosis of the entire terminal portion of the proximal tubule, it is highly unlikely to be the major determinant of other types of acute renal failure in
which tubular damage is far less severe. It is thus well
to remember that the degree of tubular injury in the
kidneys of patients with acute renal failure is highly
variable. Finckh, 9 Sevitt, 10 and others have pointed
out that classical acute renal failure may be found
without any significant tubular injury, and that no
correlation exists between the duration or severity of
renal insufficiency and the degree of tubular injury
which can be demonstrated . Similarly, acute renal
failure in man may coexist with scant, if any, evidence
of tubular obstruction with casts. 9 In sum, the overwhelming bulk of evidence presently affirms that
acute renal failure relates to a primary cessation of
glomerular filtration.
Recently, Flores et al1 1 have proposed that filtration failure is caused by endothelial and renal interstitial cell swelling. Such swelling was said to be
reversible, and renal failure prevented, by administering massive doses of mannitol. According
to the data in that report, however, renal failure was
not prevented by mannitol administration, merely
somewhat blunted. In our laboratory, closely following the technique used by Flores, we could find no
significant effect of mannitol therapy. 12 Nor have we
found a beneficial effect of hypertonic mannitol solutions in myohemoglobinuric acute renal failure other
than that which could be achieved by volume expansion with saline or plasma alone.13 Mannitol clearly
increases renal blood flow and helps maintain glomerular filtration in dogs subjected to limited hemorrhage14; however, as their renal function generally
returns to normal when renal perfusion pressure is
restored after hemorrhage whether mannitol is given
or not, one cannot presume from such studies that
mannitol prevents acute renal failure. Aortic crossclamping has also been reported to cause renal failure
which is preventable with mannitol, 15 but several investigators studying far larger numbers of animals
have been unable to duplicate any renal abnormalities at all in similarly treated animals not given mannitol.16·17
A number of clinical reports have suggested that
mannitol prevents acute renal failure in man, although no prospective study of the efficacy of such
treatment has appeared. Such a study would, how-
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ever, be difficult indeed. Assuming a 1% overall incidence of renal failure in the total population of
patients at risk after surgery, burns, trauma, or hemorrhage (a deliberate overestimate), at least 2,000
patients would need to be treated and a comparable
number employed as controls before a statistically
meaningful comparison of the two groups could be
made. Powers et al1 8 have estimated that the syndrome occurs in 0.1 % of patients at risk, a more
realistic figure that would necessitate the inclusion of
perhaps 20,000 patients in any controlled study of the
efficacy of a prophylactic measure. While patients
subjected to aneurysmectomy develop renal insufficiency more often than others subjected to less
traumatic surgery, they still have a low risk of renal
insufficiency unless the aneurysm has ruptured. In
reviewing 1,659 cases of lower aortic surgery performed in ten centers, Kountz et al1 9 found an overall
incidence of renal failure of only 3.8%. While the
physician may be reassured that none of 20 or 50
patients subjected to major surgery and treated with
mannitol will develop acute renal failure, there is
little basis for assuming that mannitol infusions are
responsible for his good luck. Similar considerations
apply to the use of furosemide as a prophylactic
agent.
The rationale for mannitol's usage rests with the
suggestion that it maintains renal blood flow, reduces
renal cell swelling, washes out tubular debris, serves
to expand vascular volume, and induces urine output
if filtration still persists. This is an impressive list of
potential benefits, but the bulk of controlled experiments show cell swelling and tubular obstruction not
to be critical to the development of acute renal failure. The syndrome can be induced readily in rats with
congenital diabetes insipidus, excreting (and drinking) a volume equal to 80% of their body weight each
day. 20 Thus, the maintenance of urine volume and
washout of tubular casts is not critical to the prevention of acute renal failure, whether this is achieved
with furosemide or with mannitol. A response to
either agent proves that acute renal failure does not
yet exist, as urine can only be formed when filtration
is ongoing.
Whether renal failure develops or not depends
largely on the type, as well as on the severity, of the
underlying injury sustained. Shock, for example, is a
major factor. While brief and modest hypotension
may, at times, lead to renal failure, the syndrome is
far more likely to occur if shock is of long duration or
poorly controlled. Volume depletion also plays a sig-
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nificant pathogenetic role, adequate volume replacement being the most important single therapeutic
modality available for the prevention of renal shutdown . The adequacy of fluid therapy cannot be
merely assumed, however, but requires documentation of adequate weight gain, appropriate changes in
urinary sodium concentrations and osmolality, and
where needed, measurement of central venous pressure and blood volume. Sepsis may predispose to
renal insufficiency not only on the basis of toxemia,
but also by the activation of intravascular coagulation.21 With prompt and vigorous treatment offiuid
volume deficits, the restoration of cardiac output to
reasonable levels, and vigorous treatment of sepsis,
the incidence of acute renal failure has become far
lower than in previous times, a reduction which is as
apparent in centers where mannitol and furosemide
are not used as "preventive agents" as in those where
they are.
While acute renal failure owing to trauma and
shock is far less prevalent nowadays, a new threat has
emerged with the widespread use of the aminoglycoside antibiotics. These agents are excreted essentially unchanged primarily by the kidney. Any impairment of glomerular filtration rate (GFR),
whether because of organic disease or as a functional
result of heart failure or dehydration, causes accumulation of these agents to a level which may be nephrotoxic. Unlike the idiosyncratic reactions to other antibiotics that occur in a very small percentage of the
population, renal toxicity can be expected in any
patient exposed to abnormally high concentrations of
aminoglycosides. The setting in which these agents
are used is one that so frequently results in some
compromise in renal function that toxic levels are
easily attained. Unlike other forms of acute renal
failure, that following aminoglycoside overdosage
may be irreversible.
How can we prevent this common and very serious complication? First, the aminoglycosides should
be used only when less toxic antibiotics cannot be
substituted. Second, renal function should be followed closely if these agents are to be given. Various
formulae are used as guides to appropriate gentamicin dosage in the face of reduced renal function,
and not one seems clearly superior to the others. All,
however, rely on the reasonably accurate assessment
of renal function. Normal serum creatinine concentrations in non-gravid adults range from 0.6 to 1.6
mg%. Thus, a value of 1.2 mg% in one patient may be

normal; in another, it may be twice normal and indicative that the G FR is reduced by one half. If one
abruptly loses all renal function, the serum creatinine
obtained two days later will be perhaps 3 mg% and
will rise progressively thereafter. It certainly would be
erroneous to assume that a creatinine concentration
of 3 mg% in such a patient means that the GFR is one
third of normal and administer gentamicin (or the
other aminoglycosides) accordingly, when, in fact,
the G FR is almost nil. The way out of the dilemma is
to routinely measure the serum creatinine concentration of any patient receiving these drugs on the day
after treatment is started. Any significant increase
should prompt a repeat determination 12 or 24 hours
later, as should any circumstance likely to lead to
worsening renal function. As serum creatinine concentrations truly reflect renal function only when they
are stable, it is imperative that serum antibiotic levels
be monitored to serve as the guide to dosage if the
creatinine concentrations are rising.
Nephrotoxic renal damage may be superimposed on preexisting renal impairment and, as previously stated, may be irreversible. Only by treating
the aminoglycosides with the greatest respect and
closely monitoring the renal function of patients receiving these drugs can overdosage and the resultant
renal failure be avoided.
To summarize, the best evidence available at
present indicates that acute renal failure represents a
sustained and severe decrease in G FR. Tubular factors are thus of secondary importance, and the term
"acute tubular necrosis" (ATN) is not pathologically
appropriate. Vasomotor nephropathy seems a better
term, and one we have adopted for this syndrome22
which in many circumstances is largely preventable
by the prompt and vigorous restoration of fluid deficits and cardiac output, as well as the treatment of
sepsis. Unfortunately, such therapy may be only marginally successful in some instances (for example,
overwhelming sepsis, acute hemorrhagic pancreatitis ), but there is scant evidence that either mannitol or furosemide protects patients from renal failure. Rather than relying on such agents, efforts
should be made to maintain normal fluid volume and
cardiac output in all cases at risk of vasomotor nephropathy.
Renal failure owing to gentamicin and other
aminoglycoside antibiotics is a result of improper
attention to dosage relative to a patient's renal function. Close attention to renal function can largely
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eliminate this common cause of renal failure.
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Pyelonephritis
WILLIAM F. FALLS, JR., M.D.
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Health Sciences Division of Virginia Commonwealth University, Richmond, Virginia

The purpose of this paper is to review current
thinking about pyelonephritis. Pyelonephritis may be
defined as a "bacterial infection of the kidney which
affects the parenchyma, the pelvis, and the calyces. It
occurs in two forms, acute and chronic."'
Clinically, acute pyelonephritis is characterized
by the symptoms of dysuria, frequency, urgency,
chills, fever, and flank pain. The urine sediment contains numerous white blood cells, bacteria, and white
blood cell casts (Fig I). A quantitative culture of the
first voided urine in the morning yields a growth of
greater than JOI' colonies per ml. Renal histologic
examination reveals an acute interstitial inflammatory reaction with polymorphonuclear leukocytes
and microabscess formation (Fig 2). If the infection
remits either spontaneously or with antibiotic therapy, the involved areas may heal with formation of a
contracted, fibrotic scar. In contrast to the acute infection, chronic pyelonephritis may be totally asymptomatic. Examination of the urine sediment usually
shows changes similar to those in acute disease except
that the quantities of cells and casts may be less
remarkable. The classic pathologic picture of chronic
pyelonephritis includes interstitial infiltration by
mononuclear cells, scarring, tubular dilatation (thyroidization) and periglomerular fibrosis (Fig 3). The
typical chronic pyelonephritic kidney is shrunken,
contains multiple scars, and is atrophic.
The pathologic picture of pyelonephritis is not
entirely specific, particularly in the chronic state
where other processes which cause an interstitial
inflammatory reaction may give a similar appearance. An incomplete list of nonbacterial causes of
Correspondence and reprint requests to Dr. William F. Falls,
Jr., Renal Section, VA Hospital, Richmond , VA 23249.
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chronic interstitial nephritis includes: analgesic
abuse, other drug toxicity, tuberculosis, sarcoidosis,
gouty nephropathy, hypercalcemic nephropathy, and
ischemic vascular disease. 2 Initially, these disorders
may be suspected because of the presence of sterile
pyuria, but later, superimposed bacterial infection
may cloud the picture.
Bacteria invade the kidney by two principal
routes: hematogenous and retrograde.3 Hematogenous spread occurs infrequently, but when it does,
it is the means whereby most staphylococcal and
streptococcal infections are initiated in the kidney.
These infections may be severe and associated with
multiple abscess formation . Most bacterial infections
of the kidney are caused by gram-negative organisms
that reach the kidney via retrograde spread from the
lower urinary tract; the natural habitat of the majority of these organisms is the gastrointestinal tract
from which they spread to the urethra and then into
the bladder and up the ureters. Approximately one
fourth of all bacterial infections involve the urinary
tract, but only a portion of these ascend above the
bladder to the renal parenchyma.
Several factors are now recognized as being of
major importance in the pathogenesis of urinary tract
infection, the first of which is sex. There is clearly a
higher incidence in females at all ages but particularly
in the childbearing years. Only in later life with the
a:dvent of prostatic hypertrophy and associated obstructive uropathy does the incidence tend to increase
in the male. The increased incidence in females probably relates to the shorter urethra, the absence of the
antibacterial action of prostatic fluids, and trauma
during intercourse. Recently it has also been recognized that disturbances in the bacterial resistance of
the vaginal vestibule secretions may be the factor
MCV QUARTERLY 14(3):132-139, 1978
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Fig I-Urine sediment from a patient with a cute pyelonephritis, showing white blood cells, a white blood cell cast, a granular cast and
numerous bacteria ( X 1,000).

which initially allows bacterial colonization of the
urethra in females.•
Instrumentation of the urinary tract is frequently
associated with introduction of bacteria into the
bladder. Unfortunately, the instrumentation is usually undertaken for evaluation of an anatomically
abnormal tract. Bladder urine is normally sterile.
When pathogenic organisms are introduced into the
bladder of a normal, unobstructed animal or man,
they are rapidly cleared because of the combined
effects of the bacteriostatic properties of normal
urine, the dilution of organisms by voiding, and the
resistance of the bladder mucosa to bacterial colonization.5 On the other hand, in the obstructed state
there is a residual pool of relatively stagnant urine;
the bacterial clearing mechanisms are no longer operative and infection ensues. In this context neurogenic
bladder dysfunction may have the same propensity to
infection as overt obstructive uropathy.

In recent years numerous studies have indicated
that ureteral reflux is probably the most important
factor which allows for initiation and perpetuation of
renal parenchymal infection. Congenital reflux becomes a problem in early childhood and is usually
caused by an abnormal placement of the ureter in the
bladder wall. 6 In the immature kidney it is likely that
even sterile reflux may result in calyceal scarring and
contracture of the parenchyma. This type of reflux
carries an ominous prognosis and frequently requires
surgical correction . Acquired reflux (Fig 4) may appear in older individuals and may be related to bladder infection, adjacent bladder diverticulae, or neurogenic mechanisms. 7 When reflux is severe, it may be
associated with intrarenal reflux in the polar regions
of the kidney. Some authorities think that this may be
the cause of atrophic pyelonephritis. 8
Dilatation of the ureters, because of pressure
from the expanding uterus, and the smooth muscle
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Fig 2-Light microscopic representation (H & Estain) of a renal biopsy section, showing the picture of acute pyelonephritis. Glomerular
architecture is relatively well maintained, but there is a marked interstitial inflammatory reaction with both polymorphonuclear and
mononuclear leukocytes. A white blood cell cast fills the collecting duct on the right. (X 80).

relaxing effects of high estrogen concentrations, may
predispose to the development of pyelonephritis in
pregnancy.a Fully 30% of pregnant patients with
asymptomatic bacilluria will have an episode of acute
pyelonephritis during a given pregnancy if left untreated .9
Controversy continues to surround the issue of
whether or not diabetes mellitus predisposes to the
development of pyelonephritis, and recent evidence
suggests that its incidence is higher in diabetic
women. 1° Clearly, when pyelonephritis develops in a
diabetic patient, the infection itself is more likely to
be severe.
The cortex appears to be relatively resistant to
bacterial colonization, and most parenchymal infections begin in the medulla where increased susceptibility to infection probably relates to the lower blood
supply to the medulla, the hypertonicity of the medullary interstitium which depresses phagocytosis, the

high level of ammonia which interferes with activation of the complement system, and the tendency for
granulocytes to emigrate from the medullary area.a
Eighty-five percent of new urinary tract infections which develop outside the hospital are caused
by Escherichia coli organisms and the remaining 15%
by other organisms, most of which are also gramnegative.11 When infection develops in the hospital
setting or occurs after instrumentation, the bacterial
flora is likely to be different and is usually composed
of gram-negative organisms with a greater degree of
bacterial resistance than E coli.
The main danger of bacterial infection of the
kidney relates to its complications. There are a number of these and one which has generated much recent
interest about its pathogenesis is atrophic pyelonephritis.8 It is now clear that this condition develops in
early life, is associated with high grades of reflux, and
may terminate in end-stage renal disease at an early
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Fig 3-Light microscopic autopsy section (H & E stain) from a patient with chronic pyelonephritis. Marked interstitial inflammatory
reaction in association with scarring, tubular dilatatio n, and periglomerular fibro sis is present. Secondary arteriolar thickening has also
occurred ( X 20).

age if the reflux is not corrected. It has been suggested
that the small shrunken kidney seen in later life may
be the result of atrophic pyelonephritis in childhood.
Papillary necrosis may be one of the most devastating complications of urinary tract infection, particularly if it occurs in diabetes mellitus with obstruction . This constellation of disturbances was formerly
associated with a high frequency of sepsis and death,
but it is seen less frequently since the advent of modern antibiotic therapy. At the present time it is more
likely that papillary necrosis may present insidiously
with slow deterioration in renal function, perhaps in
conjunction with the passage of small pieces of papillary tissue in the urine. Contemporary studies 12 suggest that this latter picture may be seen more frequently with another underlying disease such as
analgesic abuse or sickle cell disease, rather than as a
manifestation of pyelonephritis (Fig 5) .

Struvite stone formation is another common
complication of urinary tract infection and is caused
by infection with urea-splitting organisms, particularly those of the proteus species. This type of infection is seen all too frequently in patients with obstructive uropathy or neurogenic bladder dysfunction.
Under either of these circumstances a continuous
cycle of stone formation-infection-stone formation
may develop . The composition of most "staghorn"
calculi which develop in an obstructed, infected urinary tract is struvite. Infection is virtually impossible
to clear from the urine in this situation .
Perinephric abscess is an infrequent but important complication of urinary tract infection because
its onset may be insidious and it may be associated
with remarkably minimal changes in the urine sediment. It may present as a fever of unknown etiology,
and the use of modern radiographic techniques, such
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Fig 4-Voiding cystourethrogram in a patient with acute cystitis
and bilateral reflux. Moderate ureteral dilatation is present and the
contrast medium refluxes into the calyceal system. The left calyceal
system is also clearly dilated .

Fig 5-Retrograde urogram in a patient with papillary necrosis
secondary to analgesic abuse. There is marked distortion of the
calyceal system on the right. Necrotic, papillary debris is present in
several calyces, displacing the contrast medium and giving rise to
the characteristic "ring" sign.

as gallium scanning and CT scanning, may be of
great diagnostic aid. In addition, sonography of the
retroperitoneum and abdomen may be of diagnostic
help.
Gram-negative sepsis remains a frequent complication of urinary tract infection and may be associated with instrumentation or the presence of an ind wel I ing urethral catheter; therapy requires
aggressive treatment with measures to support the
circulation while administering a bactericidal antibiotic.
Whether or not chronic pyelonephritis predisposes to the development of severe hypertension
continues to be a subject of debate. Some evidence in
both children and adults would suggest that the
chronically scarred kidney may be associated with

activation of a pressor hypertensive mechanism; 13
however, most patients with chronic infection remain
normotensive or, at worse, mildly hypertensive. Perhaps a more important aspect of the association is the
fact that progression of pyelonephritis, like that of
any other type of renal disease may be accelerated by
the presence of superimposed hypertension; therefore, elevated blood pressure in a patient with pyelonephritis should be treated vigorously.
A number of disturbances in relation to pregnancy have been correlated statistically with the presence of urinary tract infection. The most notable of
these are anemia and decreased birth weight of the
fetus. After a period of skepticism about the relationship of these abnormalities to infection, recent studies
have confirmed their association. 9 As mentioned ear-
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Fig 6- Comparison of mean ± SEM values for C,,,, CPAH, a nd FF between initial measurements early aft er injury and similar determinations after more than five yea rs in 18 patients with spinal cord injuries and persislent bacilluria.

lier, there is a high incidence of acute pyelonephritis
in pregnant females with bacill uria, and this condition, clearly, should be treated. 9
For years pyelonephritis was considered to be a
major cause of end-stage renal disease. Careful evaluation of patients entering dialysis and transplant programs, however, has indicated that this is not the
case.1 4 It is likely that many of the cases of interstitial
nephritis which were thought to be caused by infection were in actuality the end result of one of the
other causes of interstitia l disease mentioned earlier.
Present estimates would suggest that no more than
15% of the patients reaching end-stage disease have
infection as the primary cause of renal failure and
virtually all of these are complicated by the presence
of stones, reflux, or other anatomic di sturbance.
Information a bout the nat ural history of urinary
tract infection in man is still incomplete. As noted
above, end-stage renal disease in the absence of an
anatomic or neurologic defect in the urin ary tract is
rare despite the frequency of culture-proven baci lluria. We have recently attempted to define more
clearly the association of chronic bacill uria and dete-

rioration in renal function by a' prospective analysis
of the changes in inulin clearance (C1n) and PAH
clearance (CPAH) in a group of patients with persistent bacilluria (spinal cord injury patients). C 1n is
a n acc urate measure of the glomerular filtration rate
and CPAH indicates the renal plasma flow.
Figure 6 demonstrates that at a mean period of
five years after the initial determinations, a statistically significa nt reduction in mean C PAH from a n
initial value of643 ml / min shortly after injury to 556
ml / min at the time o f study had occurred in 18 study
patients. Over the same period, there was no significant change in C1n; there was also a significant reduction in the filtration fraction (FF). Thi s index reflects
the ratio of C1n/ CPAH a nd is an indicator of the state
of perfusion in the kidney . Diseases which produce
renal ischemia may be associated with a low FF.
Each of the study patients had a neurogenic bladder
and persistent bacilluria. A number had experienced
one or more severe compli cations such as renal
stones, ref! ux, or sepsis. Yet, at the time of study, all
had adeq uate urinary drainage. These data suggest
that the re m ay be insidious d am age occurring to the
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kidneys of these patients; however, barring superimposition of some other insult, renal failure is unlikely
to be the cause of their death .
There will always be differences of opinion about
the work-up and therapy of patients with urinary
tract infection. Outlined below are some principles
which are generally applicable to these issues:
1. A quantitative culture, colony count, and antibiotic sensitivity determination should be
performed in all pregnant women and in all
individuals suspected of having a urinary
tract infection.
2. A patient with the typical clinical picture of
acute pyelonephritis or gram-negative sepsis
should be treated with a bactericidal antibiotic to which the organism is sensitive for at
least 10 days.
3. Radiographic studies including an intravenous pyelogram and voiding cystourethrogram should be done after the first episode of
acute pyelonephritis in the adult male and in
all children. Similar studies should be done in
any female with recurrent infection or an elevated serum creatinine. Further urologic evaluation should be done in all patients in whom
these studies identify a structural abnormality. Surgical correction of obstruction and severe reflux should be undertaken . Mild reflux
in children may be observed during a period
of antibiotic therapy and can be expected to
disappear in 50% of cases by age 6 years and
in 65% by age 14 years. 6
4. The clinical picture of cystitis and asymptomatic bacilluria may be treated with bacteriostatic agents . If recurrence occurs, ,the
above-mentioned radiologic studies should be
done. If these are negative, prophylactic or
suppressive therapy may be tried. In the future, tests for antibody coating of bacteria
may be helpful in differentiating upper tract
infection with renal parenchymal involvement from lower tract infection. 15
5. Reculture should be done after the completion of therapy for a urinary tract infection
and on several occasions over the next two
years to determine the presence of recurrence
or reinfection .
In summary, current thoughts about the pathogenesis, natural history, complications, and management of pyelonephritis have been reviewed . It is now
clear that chronic urinary tract infection in the absence of some anatomical disturbance or complica-

tion seldom leads to renal failure. Efforts should
therefore be directed toward discovering and correcting derangements in the anatomical integrity of the
urinary tract at an early stage of infection.
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Evaluation of an Abnormal Urinalysis in the
Asymptomatic Patient
DOUGLAS M. LANDWEHR, M.D., Ptt.D.

Associate Professor of Medicine, Division of N ephrology, and Director, Hemodialysis Unit, Medical College of
Virginia, Health Sciences Division of Virginia Commonwealth University, Richmond, Virginia

Physicians are occasionally presented with the
problem of evaluating a patient who has an abnormal
urinalysis 1 but who has no other sign or symptom of
genitourinary (GU) tract disease. For example, patients may present with hematuria, pyuria or slight
proteinuria, but they may have no other clinical or
laboratory abnormality to suggest glomerulonephritis, renal failure, urinary tract infection, obstruction,
hypertension, or stones. There are a wide variety of
lesions which may produce such isolated abnormalities,2·3 and a rational approach is indispensable in
preparing an efficient and definitive diagnostic plan.
The urinalysis may be abnormal because of the
presence of red blood cells, white blood cells, or
excessive amounts of albumin. To understand the
diagnostic possibilities of such abnormalities it is useful to begin by considering the sensitivity of the routine urinalysis (Table l ). Detection of the presence of
only l + albuminuria requires albumin in a concentration of 30 mg/ 100 ml. In the case of red cells and
white cells in a centrifuged urine specimen, our limits
of detection extend to recognition of a single cell
under the microscope. Let us next consider the quantity of each of these elements in a single milliliter of
blood. Blood normally contains 4 gm of albumin per
100 milliliters, which is equivalent to 40 mg/ ml.
White blood cells number approximately 10,000/
mm 3 of blood, which is equivalent to 10 million / ml.
Similarly, 5,000,000 red blood cells per mm 3 of blood
is equivalent to 5 billion / ml. Let us assume that some
Correspondence a nd reprint requests to Dr. Douglas M .
Landwehr, Division of Nephrology, Box 197, Medical College of
Virginia, Richmond , VA 23298 .
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abnormality in the GU tract leads to the loss of l ml
of blood (a relatively small amount) into the urine
each day. Assuming a modest urine volume of 1,000
ml / day, let us then examine what would be the concentration of the individual components of the urine
relative to the limits of detection. In the case of
albumin, 40 mg from l ml of blood distributed in one
liter of urine would result in a concentration of only 4
mg/ 100 ml. This is well below our detection limit of
30 mg/ 100 ml for a l + measurement. White cells
from I ml of blood distributed in 1,000 ml of urine
would result in a concentration of 100,000/ 10 ml. If
one takes 10 ml of that urine, as with the standard
urinalysis, centrifuges it and resuspends the sediment,
all 100,000 white cells are potentially identifiable;
with red blood cells, there would be an even higher
number of identifiable units in the urinalysis.
There are certain important conclusions concerning the routine urinalysis which can be drawn
from the above consideration: on one hand, it is
evident that we can detect small a mounts of bleeding
into the urine by the presence of red blood cells; on
the other hand , relatively large amounts of blood, 2040 ml/day, depending on urine volume, must be present to give detectable albuminuria. Such quantities
would contain large numbers of red blood cells and
thus result in gross hematuria. Albuminuria, detected
on the routine urinalysis and accompanied by only
microscopic hematuria, could, therefore, not reflect
simple bleeding in the GU tract. Albumin can be
separated from blood cells only in the glomerulus
and, thus, glomerular abnormalities must exist if
there is detectable albuminuria in the routine urinalysis in the absence of gross hematuria.
MCV QUARTERLY 14(3): 140-143, 1978
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TABLE 1
Sensitivity in Detection of Abnormalities of the Urinalysis
Albumin

Pyuria

Hematuria

Limits of detection

30 mg/ 100 ml

I WBC/ HPF

I RBC/ HPF

Content in I ml blood

40 mg/ L
(4.0 gm/ 100 ml)

10,000,000
(10.000/ mm')

5,000,000,000
(5 ,000,000/ mm')

Concentration when I ml blood
mixed with I liter urine

40 mg/ L
(4.0 gm/ 100 ml)

I0,000,000/ L
100,000/ 10 ml

5,000,000,000/ L
50,000,000/ 10 ml

In view of the above considerations, let us now
consider the evaluation of the patient with an abnormal urinalysis. Asymptomatic albuminuria, with or
without microscopic hematuria, indicates glomerular
leakage of protein. As we are considering asymptomatic albuminuria, this would involve only mild degrees of protein loss. Proteinuria greater than 3.5 gm /
day would not be asymptomatic or isolated, since it
would be accompanied by manifestations of the
nephrotic syndrome. Causes of asymptomatic albuminuria may be divided into functional and pathological disturbances. It is referred to as functional
when it is not permanent and when it occurs in association with other temporary physiological disturbances. Examples of this include albuminuria which
occurs with fever, exacerbations of congestive heart
failure, or severe exertion. Another kind of functional
proteinuria is that which is detectable in certain persons after prolonged standing. Such postural or orthostatic proteinuria usually involves excretion of less
than 1.5 gm of protein per day . Long-term follow-up
of most patients with postural proteinuria have indicated a good prognosis; however, in somewhat less
than 10% of cases, postural proteinuria is associated
with unequivocal glomerular disease, and here the
prognosis is more guarded.
Asymptomatic albuminuria also occurs as a
predecessor of serious disease in some patients and is
termed pathologic proteinuria. In general, certain
forms of glomerulonephritis, such as idiopathic membranous and focal sclerosing glomerulonephritis,
may initially present with isolated asymptomatic proteinuria . After a period in which there are no other
signs or symptoms of renal disease, proteinuria either
increases to nephrotic levels or progressive renal failure begins.
Having spoken of this entity as isolated and
asymptomatic proteinuria, we are presupposing that
the patient has already had a careful clinical and

laboratory evaluation which has not disclosed other
significant nephrologic abnormalities. No further
evaluation or treatment is indicated. Renal biopsy
does not contribute importantly other than providing
a more definitive prognosis. At the present time even
those types of pathologic proteinuria which may initially present as asymptomatic proteinuria do not
appear to be amenable to therapy.
Pyuria may be defined as the presence of more
than four white blood cells per high-power field from
a carefully collected urine specimen. It is usually attributable to infection in the GU tract; however, on
rare occasion, it may occur in the absence of classical
infection and without other abnormalities in the urinalysis. In these circumstances pyuria deserves special consideration. Tuberculous infection of the GU
tract, as well as infection with fungi, should be considered. Nephritis associated with systemic lupus erythematosus is a recognized cause of a urinalysis
which contains abnormal numbers of white blood
cells in the absence of other signs and symptoms of
renal disease. Rejection of the transplanted kidney
and other forms of interstitial nephritis may also on
occasion present initially with asymptomatic isolated
pyuria.
Evaluation of asymptomatic pyuria should be
undertaken when it is demonstrated in repeated urinalyses from carefully collected urine samples. Cultures for tuberculosis are indicated and intravenous
pyelography may be useful in demonstrating the
characteristic lesions of GU tract tuberculosis. In the
immunosuppressed patient or in the patient with recognized systemic fungal diseases, special cultures for
fungi should also be done. A careful clinical and
laboratory search for evidence of syste111ic lupus erythematosus should be carried out and agents such as
antibiotics and diuretics, which may potentially produce an interstitial nephritis, discontinued. Treatment, of course, is dictated by the specific diagnosis.
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TABLE 2
The Most Frequent Causes of Asymptomatic Hematuria
Urinary tract infection
Stones
Prostatic disease
Tumors:
25% incidence with gross hematuria
2% incidence with microscopic hematuria
Glomerulonephritis
Interstitial nephritis
Cystic kidney disease
Papillary necrosis
Tuberc ulosis
Hemorrhagic states
Vascular malformations

Hematuria is the most troublesome and potentially serious problem when it is encountered as an
isolated finding in the asymptomatic patient. Abnormal numbers of red blood cells may enter the urine
anywhere in the kidney or urinary tract, and may be
caused by such diverse lesions as glomerulonephritis,
benign and malignant masses, cysts, infection, and
hemorrhagic states. 4 • 5 The most frequent causes of
asymptomatic hematuria are presented in Table 2.
The incidence of each of these entities varies considerably with the age, sex, and racial background of the
patient. Although there is a significant incidence of
neoplastic lesions with microscopic hematuria, a tumor etiology is even more likely in the presence of
gross hematuria.
Evaluation of asymptomatic hematuria should
begin with a review of some aspects of the patient's
history. The patient should be questioned about the
timing of the hematuria. When it occurs upon initiation of voiding, an anterior urethral bleeding site is
suggested. When hematuria is only evident at the
termination of voiding, a site near the posterior urethra, bladder neck, or trigone is more likely. Hematuria equally present throughout urination usually
has a source above the level of the bladder. Recurrent
episodes of either gross or microscopic hematuria, in
association with upper respiratory tract illnesses, immunization, or exercise, suggest glomerulonephritis.
Symptoms of stone disease and infection should be
sought. Polycystic kidney disease and sickle cell disease frequently produce hematuria and may be suggested from a careful review of the patient's family
history . Unusual bleeding other than in the GU tract,
as well as the use of anticoagulant medications, may
lead one to suspect an underlying coagulopathy.
Careful performance of the urinalysis by the re-

sponsible physician is also important. As noted
above, when microscopic hematuria is accompanied
by qualitatively detectable albuminuria, a glomerular
origin is likely . Red blood cell casts can only form
within the tubules of the kidney and indicate a renal
origin for hematuria. Early morning urine, as well as
urine obtained after exercise, should be examined
since red cell casts may be more prevalent under these
circumstances.
As outlined in Table 3, special studies may be
required in the evaluation of hematuria. An intravenous pyelogram should be obtained in most cases;
it is especially useful for demonstrating mass lesions
in the GU tract, as well as stones and papillary necrosis. Cysts may be further evaluated with sonography
if there is any question as to malignancy; absence of
internal echoes means that a cyst is probably benign.
Cyst puncture under sonographic control allows aspiration of fluid for cytological study, as well as instillation of contrast media. Demonstration of an
irregular cyst wall strongly suggests a renal cell carcinoma.
When no cause for hematuria is apparent from
the intravenous pyelogram, or when a lesion requires
further definition , cystoscopy should be carried out.
This may permit direct visualization of bleeding sites
and, with great care, may allow sampling of urine
from individual ureters. Additionally, retrograde
pyelography may disclose lesions not demonstrable
by an intravenous pyelogram.
In cases in which cystoscopy, as well as intraverious pyelography, fails to disclose a source for
hematuria, renal arteriography should be considered.
In this way masses too small to demonstrate by the
TABLE 3
Special Studies for Asymptomatic Hematuria
I. INTRA VENOUS PY ELOG RAM -

tumors, cystic disease,
stones, papillary necrosis.

2. SONOGRAM - - -- - -- simple cyst VS tumor.

3. CYSTOSCOPY
lower GU tract lesions,
(RETROGRADE PYELOGRAPHY) evaluation of ureteral
urine.
4. R ENA L ARTERIOGRAPHY - - cyst vs tum o r, occult
tumors, vascular malform a tions.
5. RENAL BIOPSY----

glomerulonephritis,
interstitial nephritis.
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previous techniques may be localized. Additionally,
vascular malformations leading to hematuria may be
demonstrable only with arteriography. When arteriography does not disclose an abnormality and when
no bleeding is found from the lower urinary tract by
cystoscopy, hematuria is probably caused by interstitial renal disease or glomerulonephritis. Interstitial
nephritis may result from commonly used drugs such
as diuretics and antibiotics. Such agents should be
discontinued and the patient followed closely to determine whether the hematuria resolves. Glomerular
lesions are probably the most frequent cause of isolated hematuria of renal origin in the asymptomatic
patient who has no lesion demonstrable by pyelography or arteriography. In general, glomerular lesions which produce only hematuria and are not associated with other systemic abnormalities have an
excellent prognosis. They may occur at any age but
are more frequent in children and young adults.
However, other more severe forms of glomerulonephritis may occasionally present with asymptomatic
isolated hematuria. Such disease processes include
hereditary glomerulopathies, collagen vascular disease, and unresolved poststreptococcal glomerulonephritis. Thus, a diligent search for nonrenal signs and
symptoms of these diseases, as well as appropriate
laboratory tests, should be carried out.
In the patient with hematuria of renal origin and
normal renal arteriography, it may be important to
establish a definitive diagnosis by renal biopsy. If this
is not done, hematuria may recur or persist, and
physicians caring for these patients in the future may
be concerned over neoplastic lesions which might
have been missed in previous investigations. Fre-
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quently these concerns lead to multiple, unnecessary
arteriographic and cystoscopic procedures. Percutaneous renal biopsy in most such patients will
provide a definitive diagnosis and thus obviate further invasive diagnostic procedures. Additionally, the
biopsy may be useful in providing prognostic data on
the potential severity of the glomerular lesion .
As can be seen from the above discussion, evaluation of an abnormal urinalysis from an otherwise
healthy individual involves consideration of a large
number of potential diagnoses. If the meaning of
individual abnormalities in the urinalysis is not carefully considered, valuable time may be wasted and
inappropriate and expensive procedures may be performed. The general principles discussed above,
however, allow for a rational and effective approach
to this problem.
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The End-Stage Renal Disease Program
WILLIAM K. STACY, M.D.

Associate Professor of Medicine, Chief; Hemodialysis Center, McGuire Veterans Administration Hospital,
Richmond, Virginia

By the mid 1960s it had been clearly demonstrated that the lives of people with total, permanent
kidney failure could be indefinitely prolonged with
the artificial kidney and that an acceptable proportion of kidney transplants would be successful. The
extraordinary cost of this form of therapy, however,
prohibited its application to the majority of patients.
A strong lobby of health care providers and consumers sought government assistance and in the
spring of 1972 Congress passed Public Law 92-603
(Section 2991) which provided for payment of 80% of
costs for management of end-stage renal disease
(ESRD) for all persons eligible for Social Security
benefits, regardless of their ability to pay. This law
established what is, in effect, a national health insurance program for people with end-stage renal disease
and it may well be a model for future national health
insurance programs.
Until early 1977, the ESRD program was administered through the Bureau of Health Insurance of the
Social Security Administration and the Bureau of
Quality Assurance of the Public Health Service; after
that the responsibility for all administrative activity
was consolidated in the newly formed Health Care
Financing Administration (HICFA). 1 Primary responsibility for medical matters was assigned to the
Health Standards and Quality Bureau and fiscal matters to the Medicare Bureau.
To facilitate administration at the local level, the
nation was divided into 32 ESRD networks by the
Secretary of Health, Education and Welfare according to established referral patterns, modalities of
services offered, and population (Fig I ). 2 The network boundaries do not necessarily follow state or
Correspondence and reprint requests to Dr. William K . Stacy,
McGuire VA Hospital, 1201 Broad Rock Road, Richmond, VA
23249.
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other government lines. Virginia is divided among
three networks. The large central portion of the state
and the whole of West Virginia make up Network 30.
The Virginia counties of Scott and Washington are in
Network 18 with Tennessee, Alabama, and Mississippi . Four northern Virginia counties, Arlington,
Fairfax, Loudoun, and Prince William, have been
included in Network 23 with the District of Columbia
and five Maryland counties. This division of Virginia
was considered consistent with established referral
patterns and medical communications; funding for
the establishment of these networks was made available in August 1977, and all of them are now active.
Network 30 was organized in 1977 as a free-standing,
non-profit corporation called the ESRD Network
Coordinating Council of the Virginias, with offices in
Richmond.
The governing body of the network is the Network Coordinating Council (NCC). Federal regulations require that each approved ESRD care facility
provide a representative to this body and that all
health care disciplines concerned with ESRD be represented including physicians, nurses, social workers,
dietitians, technicians, and administrators. Consumers must also be represented but not as a majority.
The objective of the network is to assure that all
persons with ESRD have access to appropriate care.
The coordinating council is concerned with monitoring the quality of care and encouraging the appropriate distribution and utilization of ESRD care facilities. To avoid duplication of effort and conflict of
interest, working agreements are being developed between the networks and other agencies with similar
objectives including Professional Standards Review
Organizations (PSRO) and Health Systems Agencies
(HSA).
MCV QUARTERLY 14(3):144-147, 1978
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Fig 1-ESRD networks as designated by the Department of Health, Education and Welfare. Most of Virginia is in Network 30.

Each network is required to have a Medical Review Board (MRB) to supervise the appropriateness
and quality of care of ESRD patients. The Medical
Review Board is appointed by the NCC and consists
of a nephrologist, transplant surgeon, registered
nurse, social worker, and three additional physicians.
Standards of care are recommended by the MRB for
approval by the NCC. It is expected that this procedure will allow the establishment of high standards of
care acceptable to all health care providers. Compliance is voluntary and the NCC has no powers of
enforcement. The Network 30 MRB is completing
the first medical audit of dialysis patients, and an
ongoing review program is planned that will consider
all aspects of ESRD patient care.
The distribution and utilization of medical care
facilities have recently been the subjects of considerable discussion and government attention at all
levels; the ESRD program is no exception. The authorizing legislation requires the establishment of
minimal utilization rates of both dialysis and trans-
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Fig 2-Dialysis and transplantation activity in Virginia. Accurate
dialysis data not available for 1972, 1974, and 1976.
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ANNUAL PROJECTED COSTS OF MEDICAL SERVICES*
MEDICARE DIALYSIS AND TRANSPLANT PATIENTS
UNITED STATES, 1974-1984 **
Cost in Million Dollars

1984
1983

l

2,044

1982

l

1,808

1981

I

1,580

1980

I

1,362

1979

I

1, 153

1978

l

952

1977

l

759

1976

I

572

1975
1974

I

2,292

408
243

I

l

*Projections are based only on those inpatient and outpatient services covered by Medicare
as of December 1977.
**Calendar year.
F ig 3-Projected costs of the ESRD program. Estimates provided by the Health Care F ina ncing Adm ini strati o n, Office of Fina ncia l and
Actua ri al A nalysis- Medicare.

plant facilities. These rates have now been established
a nd all facilities must be in compliance to receive
payment for services. The NCC h as n o authority to
regulate utilization or distribution of facilities, but it
is expected that it will provide consultation to HSAs
and state health departments in these matters.
A national E nd-Stage R enal Disease M edica l
Information System (ESRD MIS) is being developed

to collect data on the types of facilities a nd services
provided and on the course of illness of patients with
ES RD. It is anticipated that the data generated will
provide basic in format ion to assess and evaluate the
quality of care provided to ES RD patients a nd the
type of informat ion needed for effecti ve health care
delivery planning. This system replaced the Huma n
Renal Transpl a nt Registry and the National Dia lysis

STACY: END-STAGE RENAL DISEASE PROGRAM

147

Registry. Unfortunately, this new system has been
slow in starting and only limited data regarding
ESRD patients have been published since the other
registries ceased operation in 1976.
As expected, the number of patients receiving
ESRD care has rapidly increased since 1972. According to the National Dialysis Registry, there were only
2,426 patients receiving dialysis in the United States
in 1970. 3 By June 1977 the Social Security Administration estimated that 33,371 persons were receiving
dialysis treatment in over 800 facilities under the
ESRD programs. 2 Transplantation activity has increased also but not quite so rapidly.• The growth of
dialysis and transplant activity in Virginia has generally paralleled that of the nation (Fig 2). 5 There are
approximately 27 dialysis facilities and 4 transplant
programs [University of Virginia, Medical College of
Virginia, VA Hospital (Richmond), Eastern Virginia
Medical School] in this state. The basic needs of the
patient population are being met. There remain , however, some areas where the distance to a facility is
unacceptably long. This is particularly true in the
south central and southwestern portions of the state,
but it is expected that units will soon be organized in
these poorly covered areas. Considerable effort is
being made to increase transplant activity, particularly by improving cadaver organ procurement.
The ultimate size of the ESRD program is difficult to predict. It has been estimated that 50-75 new
ESRD patients per million population per year will
be candidates for treatment. This may well be a low
estimate, since practically all patients are now considered candidates for some form of treatment. The
Social Security Administration predicts 55,900 patients will be receiving treatment by 1982. 2
The cost of this program is staggering. According to the most recent projections, expenditures for
1978 will approach $1.0 billion and will be $3.0 billion annually by 1984 (Fig 3). 2 The cost of maintaining a chronic dialysis patient who receives dialysis in
a center approaches $25,000 per year. A saving of
$8,000 to $10,000 annually is realized if the same
patient performs self-dialysis at home. The cost of a
successful transplant is approximately $25,000 the

first year and $1,000 to $3,000 each year thereafter. 6
It is very likely that legislation will be passed in 1978
that will provide incentives for both health care providers and consumers to employ the less expensive
alternatives. Changes in reimbursement procedures
are also expected. These measures will help, but important changes in the artificial kidney and considerable improvement in transplant results will be required before major cost reductions are possible.
In summary, a national health insurance program for people with permanent failure of one organ
system is well established. Appropriate care for most
Americans with ESRD is readily available and
affordable. The program, though effective and growing rapidly, is extremely expensive and cost containment is the major concern of health care providers
and the government. The mechanism of administration of this program may well be the model for future
national health insurance programs.
Figures l and 3 are reproduced by permission from the US
Department of Health , Education and Welfare.
Figure 2 is abstracted from The Renal Program of Virginia
1977.
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Diabetic Nephropathy
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Any discussion of morbid events in diabetes is
going to emphasize cardiovascular and peripheral
vascular problems. Renal disease accounts for a relatively small percentage of the mortality in diabetes;
yet the overall incidence of diabetes mellitus in the
population so greatly exceeds that of the various
types of glomerulonephritis that it has become one of
the most common causes of end-stage renal failure in
this country. It is difficult to assign exact numbers
because the figures in the medical literature vary considerably; however, it is estimated that in the United
States today there are some I 0 million people who are
known to be diabetic, who would be found to be
diabetic if tested, or who during the course of their
lives will develop overt diabetes. In autopsy series of
diabetics the prevalence of glomerulosclerosis has
varied from 15% to 82%, with a mean of approximately 30% . This figure will vary depending on how
carefully the kidneys are studied, particularly with
respect to the use of special stains for identifying
glomerulosclerosis; the incidence will also increase
with the proportion ofjuvenile to adult onset diabetics included in the sample. Renal failure is listed as
the cause of death of 6% to 12% of diabetics, and its
incidence is increased seventeenfold in the diabetic
population as compared to the nondiabetic. These
figures are probably applicable to those diabetics who
have many complications and who require referral to
major medical centers for treatment. In terms of the
general diabetic population renal failure is probably
in the range of 1% to 2%. This means that the prevalence of glomerulosclerosis is severalfold higher than
Correspondence and reprint requests to Dr. Barry B. Kirschbaum , Division of Nephrology, Box 197, Medical College of Virginia, Richmond, VA 23298.
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the prevalence of renal failure, and that simply finding the lesion on biopsy does not indicate that kidney
function itself has been impaired or that there will be
any abnormalities present on urinalysis. As a cause of
end-stage renal failure, diabetes now accounts for
some 15% to 25% of all new cases.
Five years' survival after onset of proteinuria in
diabetics compared to age-matched controls is 65%
opposed to 73% for diabetics who do not develop
proteinuria and 83% for non-diabetics. This does not
mean that these people are dying of renal disease but
that proteinuria heralds increased mortality from all
causes. For juvenile diabetics it is extremely unusual
for proteinuria to develop before 10 years' duration
of the disease or to appear after a protein-free interval greater than 30 years. This means that there are
essentially two populations of juvenile diabetics with
regard to the kidney; those who will have their disease for an unlimited amount of time and never develop renal complications, and those who during the
period between 10 and 30 years will note the onset of
renal problems. Finally, in juvenile diabetes mellitus,
azotemia defined as BUN in excess of 30 mg percent
implies end-stage renal failure within three years. An
important point to note is the rarity of a decline in the
glomerular filtration rate before the onset of proteinuria when the cause is diabetic nephropathy. Once
renal failure does ensue it has been calculated that the
glomerular filtration rate falls at an average rate of 1
ml/min each month. With other forms of renal disease, hypertension greatly accelerates the rate of decline in the glomerular filtration rate, an important
point in treatment.
Diabetic nephropathy and microangiopathy are
the main topics under discussion here, but there are
. several other factors which contribute in varying deMCV QUARTERLY 14(3):148-152, 1978
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gree to the progression of renal failure in diabetics.
As there is no therapy for diabetic nephropathy itself,
these other factors assume an importance in line with
their response to treatment. Infection, in particular
pyelonephritis and papillary necrosis, becomes an extremely important factor in the management of the
diabetic. This is true because the autonomic neuropathy that may complicate diabetes favors development
of a neurogenic bladder with high residual urine
which may lead to reflux up the ureter, if the urine is
infected, this reflux will result in secondary pyelonephritis and subsequent papillary necrosis with rapid
loss of renal function . In patients who already have
some type of renal failure, infection, even without
involvement of the renal parenchyma, can result in a
further decline in renal function. One of the theories
that has been advocated to explain this is that certain
types of bacteria can attach themselves to the cells of
the ureter and thereby compromise the peristaltic
action of the ureter which is important in propelling
urine from the renal pelvis into the bladder. This
results in a type of functional obstruction which acts
in the same way as a true obstruction. Treatment of
these patients with antibiotics to eradicate the bacteriuria improves ureteral peristalsis and renal function
as well.
Diabetes is also frequently complicated by hyperlipidemia and hyperuricemia. Uric acid crystals
are a cause of interstitial nephritis, and high uric acid
levels which lead to increased uric acid excretion can
set the stage for uric acid calculi, obstruction, and
subsequent infection. In the evaluation of a diabetic
patient, the potential adverse effect of uric acid
should be considered as this cause of renal failure is
subject to therapy either by alkalinization of the urine
or the use of allopurinol.
A number of cardiovascular problems will also
contribute to the declining glomerular filtration rate.
Hypertension has already been mentioned; this can
accelerate the vascular degenerative changes in the
kidney, leading to nephrosclerosis which in turn can
accelerate the hypertension, creating a cycle which
may be interrupted if the hypertension is successfully
controlled through the careful use of antihypertensive
medication. Another complication of hypertension is
its deleterious effect on the myocardium, leading to
hypertensive cardiomyopathy and congestive heart
failure. This will have an adverse effect on renal function, for as the kidney is damaged secondary to diabetes or other processes and as the vascular disease in
the kidney progresses, autoregulation of blood flow
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in the face of a reduced cardiac output is compromised; thw; low-output congestive heart failure
will result in prerenal azotemia superimposed on the
preexisting ren.il failure. In general, this situation is
handled by the combination of digitalization and diuretics; however, it is worth pointing out the problems associated with excessive use of diuretics in these
patients. They may get too dehydrated, a factor that
will superimpose a prerenal type of azotemia upon
their already preexisting level of renal failure. A compromise has to be worked out in terms of controlling
the symptoms of congestive heart failure without, at
the same time, contributing further to the impairment
of renal function. Diabetics are prone to develop
atherosclerosis, and particularly those patients who
have extremely severe atheromatous disease of the
aorta are subject to embolization to the renal vessels.
This can present as episodic elevations of blood pressure associated with fluctuations in the level of renal
function reflected by BUN and creatinine and accompanied by microscopic or even gross hematuria, depending on how much of the kidney is damaged or
destroyed by infarction.
The actual role of platelets in renal disease is still
largely uncertain, although there is strong circumstantial evidence that platelets may be an important
factor in the decline in renal function not only in
diabetes but in glomerulonephritis as well. However,
the abnormal properties of platelets in diabetes increase the level of suspicion that they have a major
role in the pathogenesis of the renal disease.' In the
laboratory, platelets are studied by incubating them
with various agents such as adenosine diphosphate,
epinephrine, and collagen, which induce aggregation .
The Table shows that the percent aggregation of
platelets in diabetics to all three aggregating agents
exceeds the control sample; moreover, platelets from
diabetics aggregate at a lower concentration of these
agents than the control sample. The reason for this is
not exactly clear, but there is current evidence for a
disturbance of prostaglandin synthesis by the platelets of diabetics. The Figure shows the synthesis of
immunoreactive prostaglandin E following the addition of a precursor of prostaglandin synthesis, arachidonic acid. Diabetic platelets show enhancement of
prostaglandin formation following addition of the
precursor. Thus with the evidence that platelets are
more sticky in the diabetic and aggregate more easily,
the possibility has been raised that within the microcirculation of the kidney, platelet aggregation occurs
and leads to occlusion of the small blood vessels,
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TABLE
Percent Aggregation Four Minutes After the Addition of Each of
the Aggregating Agents

AGGREGATING
AGENT
ADP:
lµM

AGGREGATION(%)
DIABETIC
CONTROLS
SUBJECTS

P VALUE*

22 ± 7t
69 ± 4
76 ± 4

80 ± 4 (9):j:
88 ± 4(9)
86 ± 3 (9)

< 0.001
< 0.005
NS§

2µM
5µM

39 ± 8
60 ± 6
66 ± 6

82 ± 5 (10)
85 ± 3(9)
84 ± 2(10)

< 0.001
< 0.01
< 0.005

Collagen:
1 µg/ ml
2µg / ml
lOµg / ml

53 ± 10
69 ± 8
77 ± 8

80 ± 3 (8)
84 ± 4 (8)
86±3(8)

<0.05
NS
<0.05

2µM
5µM
Epinephrine:
lµM

* Difference between % aggregation seen in the platelet-rich
plasma obtained from control and that in diabetic subjects.
t Mean± SEM.
:j: Figures in parentheses denote no. of subjects
§ Not significant.

resulting in glomerular ischemia and glomerulosclerosis. There is some further evidence that involves
platelets: thromboglobulin, a protein which is derived
from the platelet, has been found to be increased in
the circulation of those diabetics who have microangiopathy. There are also tests for the presence of
circulating platelet aggregates, and those diabetics
who have the most severe small vessel disease are also
the ones who show the highest levels of these circulating platelet aggregates. A recent study2 reported on
the efficacy of sulfinpyrazone in the prevention of
morbid events in patients who have severe coronary
artery disease. There are active studies in progress to
evaluate antiplatelet drugs in a variety of diseases
that affect blood vessels, particularly coronary artery
disease, atherosclerosis, and different types of renal
disease.
Amyloidosis is always listed as associated with
diabetes mellitus. Certainly the onset of nephrotic
syndrome or heavy proteinuria in a patient with longstanding diabetes does raise the possibility that secondary amyloidosis may be present. With respect to
immunologic factors which crop up in consideration
of almost every type of renal disease, immunoglobulins and complements are found within the
glomerulus of the diabetic kidney. Their presence in a
rather nonspecific pattern together with several other
serum proteins has been interpreted not to represent
a specific immunologic event such as immune complex disease or anti-glomerular basement membrane

(anti-GBM) disease. Still, there are some lines of
evidence which do not exclude completely the idea
that immunologic problems are present in the diabetic and may be contributing to the renal disease. It
was recently reported that juvenile .d iabetes mellitus
can be viewed as a genetic disease transmitted as an
autosomal recessive gene. 3 More interesting, perhaps,
is the close association of the diabetic gene with the
HL-A locus. This area of the chromosome is concerned with a variety of immunologic responses, and
many other diseases which have a close association
with the HL-A locus have been more firmly established as being the result of an immunologic abnormality. Based on this there is still speculation that the
diabetic may have altered immunologic responses
and that this in turn may lead to primary or secondary renal damage.
Drug-induced disease of the kidney, while not confined to the diabetic, may assume increased signficance
for these patients. There have been several reports of
acute renal failure following the use of iodine contrast agents; for the most part, this can be prevented
in the nondiabetic population by avoiding dehy-
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dration which is part of the preparation of patients
for radiologic examinations. Diabetics, however,
tend to develop acute renal failure with a greater
frequency than nondiabetics; moreover, avoiding dehydration does not seem to be protective. This suggests that something about the diabetic kidney predisposes it to damage in the face of a quantity of
hyperosomotic material. The question arises whether
the diabetic kidney is more susceptible to other nephrotoxic agents such as the aminoglycoside antibiotics
and a host of other medications which have potential
nephrotoxicity. The lack of a definite answer suggests
that in the management of diabetics both diagnostic
and therapeutic agents should be selected for their
reduced incidence of nephrotoxicity.
Several studies have attempted to identify factors of importance in determining the development
and progression of diabetic nephropathy. The data to
be presented were derived from a small number of
patients with biopsy-proven glomerulosclerosis who
were followed for several years at which time a repeat
biopsy was performed.' As far as the type of diabetes
is concerned, of the 11 adult onset diabetics, 9
showed no progression of their glomerulosclerosis,
and 2 became worse. In contrast, of the 6 juvenile
diabetics, l showed no change and 5 showed progression of the disease. With regard to blood glucose
control, 6 of the patients maintained good sugar control for the whole length of the study and none of the
6 showed progression of their glomerulosclerosis. By
contrast, 13 patients were rated to be poorly controlled and IO of them showed a progression of their
renal lesions. In respect to the age of onset of these
diabetics, patients in the group that showed no
change were considerably older at the time of the
onset of their diabetes than were those in the group
that became worse. Obviously these three variables
are not independent since, by and large, in older
patients the adult onset type of diabetes can easily be
managed by diet and weight reduction. But the results do suggest that blood glucose control may be
important in terms of slowing down or averting the
development of glomerulosclerosis.
There appear then to be at least three phases in
the renal disease that accompanies diabetes. The first
is a pre-proteinuria phase. Phase 2 is marked by the
onset of proteinuria, and phase 3 would be development of azotemia. Several groups have tried to study
the question, Is there anything abnormal about the
kidney in the pre-proteinuric phase?, that is, before
proteinuria becomes manifest and at a time when the
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other renal function tests are also normal. 6 If glomerulosclerosis progresses slowly with time, there
might be a gradual increase in the excretion of albumin in the urine as the function of the duration of the
diabetic process until such time as the amount of
albumin in the urine definitely reaches an abnormal
quantity. In a study of 97 young male diabetics who
were followed from 1-19 or more years after the
diagnosis of diabetes, there was no increase in albumin excretion throughout this period of time. Those
who develop proteinuria are clearly distinguished
from those who do not. Because strenuous exercise
increases albumin excretion, a group of 13 juvenile
diabetics were exercised at a rate which had not affected urinary albumin levels in 9 normal controls.
The diabetics showed a statistically significant increase in protein excretion that returned to baseline
after stopping the exercise. Another element that has
been examined is the excretion of low molecular
weight proteins by diabetics; these represent proteins
that are considerably smaller than albumin and are
freely filtered at the glomerulus. Almost none, however, appear in the urine because most of these filtered proteins are reabsorbed by the cells of the proximal tubule. In the pre-proteinuric phase, diabetics
show an increase in excretion of low molecular
weight proteins. These results, together with additional information on albumin excretion, suggest that
the metabolic state of diabetes can adversely affect
renal cell function so that when the diabetic is poorly
controlled, the cells are less able to reabsorb filtered
proteins, including albumin.
In addition to studies on patients, there have
been attempts to gain information about diabetes
through the use of animal models. Diabetes may be
induced in animals either by removing the pancreas
or by destroying the insulin-producing cells with a
chemical such as streptozotocin. These animals then
develop hyperglycemia and over the next several
months their kidneys will show the kind of lesions
that are present in humans: namely, there is an increase in the mesangial matrix and an increase in the
degree of glomerulosclerosis together with deposition
of immunoglobulins and complement. If the kidneys
from a diabetic animal are transplanted into a normal
animal, the diabetic changes rapidly disappear. On
the other hand, if kidneys from a normal animal are
transplanted into a diabetic animal, diabetic changes
will develop. When pancreatic tissue is successfully
transplanted into the diabetic animal, then coincident
with the rise in insulin level, there is striking improve-

152

ment in the appearance of the diabetic kidney. This
indicates that the changes seen in the glomerulus are
at least initially reversible and that metabolic control
of blood glucose, or at least the presence of insulin in
appropriate quantities to keep the blood glucose normal, is a contributing factor to the development of
diabetic changes.
The outline for therapy of diabetic kidney disease calls for the best blood glucose control circumstances will permit. Antihypertensive therapy has to
be emphasized together with optimal management of
congestive cardiac failure in order to maintain a high
cardiac output and avoid prerenal azotemia. The patient should be evaluated for obstruction and for
urinary tract infection. Nephrotoxic agents should be
avoided as much as possible. As for vascular complications, anticoagulation offers little value as, by and
large, patients who have renal disease also have retinal disease which is aggravated by these drugs. The
antiplatelet drugs, based on available evidence, are
quite promising, although unproven at the present
time. As far as the treatment of end-stage renal disease in the diabetic is concerned, the same four modalities are open to these patients as anyone else:
living related transplants, cadaver transplants, hemodialysis and peritoneal dialysis . Because of technical
advances, greater experience in dealing with diabetics, and earlier acceptance of diabetics into end-stage
renal failure programs, the prognosis has improved
considerably during the past couple of years.6 Transplantation from a living related donor seems to be as
good in diabetics as in the general population, so that
this would seem to be the treatment of choice for a
diabetic with end-stage renal disease. The results with
cadaver kidney transplantation tend to be poorer
than those of the general population and until we
have some better methods of managing cadaver kidney transplants in general, this is probably the least
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promising mode of therapy for the diabetic. Hemodialysis is the treatment that will be applied to the
majority of these people. The problems are in establishing a suitable blood access site because of severe
vascular disease and the requirement for anticoagulation during dialysis which frequently leads to
a deterioration of vision. Many nephrologists now
feel that the treatment of choice if a living related
donor is not available is peritoneal dialysis; the major
problem here is peritonitis as well as the necessity for
using high-glucose containing solutions in the peritoneal cavity which can lead to severe degrees of hyperglycemia, but the complications associated with
bleeding in the eye are avoided and vascular access is
not necessary.
The table and the figure are reproduced with permission from
the New England J ournal of Medicine (297: 1306-1310, 1977).
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